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INTRODUCTION
“I was angered, for I had no shoes. Then I met a man who had no feet. ”
                                                                                               - Chinese Proverb
Poets have waxed eloquent of their grace, romantics have offered their hearts under their 
beloved’s feet, yet the feet remain the most neglected part in our body. As the Chinese proverb has 
succinctly pointed out the pathos of a life without feet, the prevention of amputation becomes poignant 
in today’s world where chronic diseases like diabetes have increased the rates of foot amputation.
Diabetes mellitus with its multisystem affliction has emerged as the scourge of the 21st century, 
reaching pandemic proportion and causing devastating consequences. Foot ulcers are a significant 
complication of diabetes mellitus and often lead to lower-extremity amputation. Approximately 85 
percent of all diabetes-related lower-extremity amputations are preceded by foot ulcers84.They are the 
most common cause of disability and hospitalization in patients with diabetes and are the disease’s 
most expensive complication. The WHO defines diabetic foot as “Infection, ulceration and/or 
destruction of deep tissues associated with neurological abnormalities and various degrees of peripheral 
vascular disease in the lower limb” (WHO, 1985)12.
The underlying etiologies are neuropathy, trauma, deformity, high plantar pressures, infection, 
impaired wound healing, limited joint mobility and peripheral arterial disease. These factors lead to 
foot ulceration, gangrene and, finally, amputation if appropriate intervention is not applied.
Diabetic ulcers are at high risk of infection secondary to impaired leukocyte chemotaxis and 
phagocytosis. High glucose levels and poor tissue perfusion may compound this condition. Decreased 
ability  to  fight  off  infection  combined  with  tissue  hypoxia  creates  an  ideal  environment  for  a 
necrotizing infection. Limb-threatening diabetic infections are usually polymicrobial involving multiple 
aerobic  and  anaerobic  infections.  Staphylococcus  aureus, Streptococcus  spp.,  Enterobacteriaceae, 
Bacteroides  fragilis,  Peptococcus  spp.  and Peptostreptococcus  spp. may be cultured from diabetic 
ulcers.
           Proper choice of antimicrobials in the treatment of a limb-threatening diabetic foot ulcer 
infection  is  imperative  as  it  should  include  those  with  activity  against  Gram-positive  and  Gram-
negative  organisms  and  provide  aerobic  and  anaerobic  coverage.  Prompt  initiation  of  appropriate 
antibiotic therapy, as well as surgical debridement of necrotic or devascularized soft tissue and bone, 
are essential for controlling the infection and preventing additional morbidity.
Management of the diabetic foot requires a thorough knowledge of the major risk factors for 
amputation,  frequent routine evaluation and meticulous preventive maintenance.  A careful physical 
examination, buttressed by monofilament testing for neuropathy and noninvasive testing for arterial 
insufficiency,  can  identify  patients  at  risk  for  foot  ulcers  and  appropriately  classify  patients  who 
already have ulcers or other diabetic foot complications.
            Patient education regarding foot hygiene, nail care and proper footwear is crucial to reducing 
the risk of an injury that can lead to ulcer formation. The aim of therapy should be early intervention to 
allow  prompt  healing  of  the  lesion  and  prevent  recurrence  once  it  is  healed.  Multidisciplinary 
management  programs  that  focus  on  prevention,  education,  regular  foot  examinations,  aggressive 
intervention, and optimal use of therapeutic footwear will lead to significant reductions in the incidence 
of lower-extremity amputations. 
AIM OF THE STUDY
1. To evaluate the precipitating cause, severity and complications of foot ulcers of patients 
with diabetic foot treated in our hospital.
2. To identify the aerobic, anaerobic and fungal pathogens involved in the different grades 
of diabetic foot ulcers.
3. To establish an effective antimicrobial regimen for empirical treatment of diabetic foot 
infections.
REVIEW OF LITERATURE
Diabetes mellitus is a clinical  syndrome characterized by hyperglycemia due to absolute or 
relative deficiency of insulin. It is one of the oldest metabolic diseases known to mankind. The earliest 
known  record  of  diabetes  written  in  Egyptian  papyrus  of  1500  BC  mentions  polyuria  (frequent 
urination) as a symptom. In 500 BC, two Indian Physicians, Susruta and Charaka were the first to 
recognize the sweetness of diabetic urine .The term ‘diabetes’ was first described in 2nd  Century A.D 
by Arateus of Cappadocia from the Greek word for a siphon. He gave a graphic account of the disease 
as 'the melting down of flesh and limbs into urine’. Avicenna (960-1037) defined the clinical features 
of diabetes and described gangrene and impotence as its effects. Up to the 11th Century, diabetes was 
commonly diagnosed by 'water tasters,' who drank the urine of those suspected of having diabetes as 
the urine of people with diabetes was thought to be sweet-tasting. The Latin word for honey (referring 
to its sweetness), 'mellitus', was added to the term diabetes as a result. In 1869 Paul Langerhans, a 
German medical student discovered that the pancreas contains two systems of cells. One set secretes 
the normal pancreatic juice while the function of the other was unknown. Several years later, these cells 
were identified as the 'islets of Langerhans. In 1893 Gustav Laguesse suggested that these islets were 
responsible for regulating glucose metabolism. In 1909, Jean de Meyer gave the name ‘insuline’ to this 
hypothetical product of the islets. On clinical grounds, Diabetes was subdivided initially into diabete  
maigre (lean) and diabete  gras  (obese)  and later  into insulin  dependent  (type 1)  and insulin  non-
dependent (type 2) subtypes. (33)
Neuropathic symptoms in diabetic patients had been mentioned by Rollo at the end of the 18th 
century and Marchal de Calvi concluded in 1864 that nerve damage was a specific complication of 
diabetes.  In 1885, the Guy’s Hospital  physician,  Frederick Pavy gave a description of neuropathic 
symptoms as “The usual account given by these patients of their condition is that they cannot feel 
properly in their legs, that their feet are numb, and that their legs seem too heavy” (85)
Insulin was discovered at the University of Toronto in 1921 by Frederick Banting and Charles 
Best. The term ‘insulin’ was coined by Macleod. The primary sequence of insulin was reported in 1955 
by Frederick Sanger. Milestones in insulin pharmacology include the preparation of delayed action 
insulin by Hagedorn in 1930s; the production of synthetic human-sequence insulin in 1979 and recently 
of  novel  insulin  analogues  by  recombinant  DNA  technology.  The  first  oral  hypoglycemic  agents 
available  were  the  sulphonylureas  in  the  early  1940s.The  biguanides  phenformin  and  metformin 
became available in 1959 and 1960 respectively33.
EPIDEMIOLOGY OF THE DIABETIC FOOT PROBLEM
One  third  of  all  diabetic  patients  have  significant  peripheral  neuropathy  and/or  peripheral 
vascular disease, the main risk factors for foot ulceration. 3-10% of those with diabetes have a foot 
ulcer and the life time risk for the diabetic patient to develop one is around 15%. The average age of 
the patient suffering from diabetic foot problem is over 60 years84. 
Amputations: People with diabetes are 10-15 times more likely to have a lower limb amputation 
than non-diabetic individuals5. 50% of all Lower Extremity Amputations (LEA) are diabetes related 
and >70% of LEA’s are preceded by a foot ulcer. Infection was the second most frequent indication, 
next to gangrene for diabetic lower extremity amputation  22.Up to 20% of patients with diabetic foot 
undergo  an  ipsilateral  amputation  within  12  months  and  nearly  50%  undergo  a  contra  lateral 
amputation within 1-3 years. Life expectancy is also reduced as a result. The 3 year mortality after 
amputation is 20-50%5, 12. The recurrence rates of a healed neuropathic ulcer may be as high as 70% 
over the next 5 years. Hospitalized diabetics are 2.8 times more likely to die in the hospital and their 
length of stay is 59% more than that of non diabetics29.
ETIOPATHOGENESIS OF FOOT ULCER
Foot ulceration occurs as a result of trauma in the presence of neuropathy and/or peripheral 
vascular disease with infection occurring as a secondary phenomenon. Interplay of all four factors is 
usually involved. Diabetic foot ulcers can be broadly classified into three types:
1. Neuropathic
2. Ischemic
3. Neuroischemic.
  TRAUMA:
              Trauma is usually trivial and often goes unnoticed due to the loss of pain sensation. The 
various mechanisms of injury that destroy the foot include:
1) Direct mechanical disruption of tissue 
2) Small amount of force that is sustained over time that leads to ischemia and
3) Moderate amount of force that is repeated over and over that leads to inflammation and 
enzymatic autolysis of tissue.
NEUROPATHY 
Neuropathy accounts for over one half of ulcers. Motor, Sensory and Autonomic neuropathy 
occurs .Sensory neuropathy occurs as symmetrical glove and stocking distribution and causes loss of 
protective pain sensation 15.The intrinsic muscles of the foot are weakened due to the motor component 
of neuropathy and leads to the characteristic ‘neuropathic posture’ of raised arch, clawed toes and  high 
pressure  concentrated  on  the  metatarsal  heads  and  heel.  Shear  forces  generated  during  walking 
stimulate skin thickening (callus) on these pressure points and areas of hemorrhage or necrosis that 
commonly develop within the callus can breakthrough to the surface to form an ulcer. Callus formation 
is therefore an important prediction for ulceration. 
           Autonomic neuropathy leads to reduced sweating which causes the skin to dry out and crack 
easily, allowing the entry and spread of infection16. Severe autonomic dysfunction leads to Charcot 
arthropathy, a rare but important cause of foot deformity that leads to pressure ulceration.
 ISCHEMIA
Ischemia is primarily due to peripheral arterial disease. It compromises the supply of oxygen 
and nutrients to the tissues and delays the healing of foot ulcers. In diabetics, there is a predilection for 
the smaller  arteries arising at  the trifurcation of the popliteal  artery to get  affected.  Pure ischemia 
accounts for less than 10% of cases while one third of foot ulcers are neuroischemic.
INFECTION
           Infection may begin superficially in an ulcer or crack in the skin, but may spread to involve the 
deep tissues including tendons and bones.  It  is  usually caused by organisms from the surrounding 
tissues. The potential for a wound to become infected is determined by two main factors: the micro-
organic contamination of the wound; and the person’s resistance to that contamination44.  Infections 
related to superficial ulceration are most commonly caused by aerobic gram-positive cocci. Cellulitis of 
non- ulcerated skin is nearly always caused by  Streptococci sp. or S aureus. S. aureus is the most 
commonly isolated  pathogen and accounts  for  most  infections  in  which  only a  single  pathogen is 
recovered.  Coagulase-negative  staphylococci,  enterococci,  and  group  B  streptococci  are  also 
frequently isolated. Streptococci secrete hyaluronidase which facilitates spread of the necrotizing toxins 
of Staphylococci. Enzymes from these bacteria are also angiotoxic and cause in situ thrombosis of the 
vessels. If both vessels are thrombosed in the toe it leads to necrosis and gangrene. 
In  deep  seated  infections,  aerobic  gram  negative  bacteria  and  anaerobic  bacteria  flourish. 
Proteus species, Escherichia coli, and members of the  Klebsiella sp and  Enterobacter species have 
been isolated most often. Anaerobic isolates are often found when appropriate collection techniques are 
used. Bacteroides species, Clostridium species, and anaerobic streptococci, such as Peptococcus spp 
and Peptostreptococcus species, are the most common anaerobic pathogens involved in diabetic foot 
infections.
Necrotizing infections involving gas forming organisms can cause gas gangrene and septicemia 
might  occur.  Both  aerobic  and  anaerobic  bacteria  can  spread  to  the  blood  stream and  cause  life 
threatening  septicemia.  Severe  sepsis  is  often  associated  with  gas  in  the  soft  tissues.  Although 
Clostridial organisms  have  been  previously  held  responsible  for  this  presentation,  non  Clostridial 
organisms are more frequently the offending pathogens. These include  Bacteroides, Escherichia and 
anaerobic Streptococci. 
Fungal infections also occur but usually do not cause systemic upset. However, infections of toe 
nails and interdigital spaces by  Trichophyton and  Candida albicans can serve as portal of entry for 
bacteria21.
RISK FACTORS FOR FOOT ULCERATION
Early identification of risk factors  for  diabetic  foot  ulcer  and initiation of proper  treatment 
reduce the occurrence of complications, including the need for amputation. The various factors are 
neuropathy, structural deformity or limited joint mobility, previous history of ulceration or amputation, 
and poor glucose control37. Effects of these risk factors are cumulative. The demographic risk factors 
include older age, male gender, ethnicity and even social situations like living alone. 
Diabetes Related Risk Factors
Lavery et al47 in their study showed that an elevated plantar pressure (>65 N/cm2), history of 
amputation, lengthy duration of diabetes (>10 years), foot deformities (hallux rigidus or hammer toes), 
male sex, poor diabetes control (glycosylated hemoglobin >9%), 1 or more subjective symptoms of 
neuropathy, and an elevated vibration perception threshold (>25 V) were significantly associated with 
foot ulceration.
Peripheral vascular disease though 4 times more common in those with diabetes were more 
associated with a risk for amputation than the development of foot ulcer per se.
Increased plantar pressures: Veves79, 38 and colleagues demonstrated that plantar foot pressures 
in diabetic patients are strongly predictive of subsequent plantar ulceration, especially in the presence 
of neuropathy.
Advanced Glycosylated End products cause glycation of collagen and restrict movement of key 
joints and limits joint mobility. 
Diabetes  mellitus  being  an  immune  suppressed  state,  impaired  neutrophil  chemotaxis  and 
phagocytosis makes the foot more prone for infections 61
Past history of amputation and ulcer were independently related to risk of ulcer. About 60% of 
diabetic patients with a history of foot ulcer will develop another ulcer within a year following healing. 
This is due to three distinct factors. First, the risk factors responsible for the previous ulceration are still 
present. Second, the skin over the previous ulcer site maybe weakened and finally, the deformity and 
biomechanical imbalances may create areas of high pressure leading to recurrence. After a great toe 
amputation, pressure distribution of the foot is significantly altered. Because pre-amputation risk factors 
such as peripheral neuropathy, foot deformity, and limited joint mobility for many of these patients 
remain unchanged, an increase in foot pressures contributes to an increased risk of reulceration and 
reamputation in these patients45. 
Behavioral risk factors: Self management skills are highly correlated to the presence of diabetic 
foot complications.
Other risk factors include body weight which is in higher prevalence in type 2 diabetics.  One 
potential mechanism for the higher risk associated with greater weight is increased plantar pressure in 
heavier subjects23.
Insulin  use  and history  of  poor  vision  are  independently  related  to  higher  ulcer  risk.  It  is 
possible that  both of these factors reflect  diabetes severity.  Also, poor vision may interfere with a 
patient’s ability to detect early foot lesions that without attention might progress to non-healing ulcer.
Interaction of risk factors
Boyko  et  al  in  the  Seattle  Diabetic  Foot  Study  had  concluded  that  multiple  mechanisms 
contribute to the development of diabetic foot ulcer. Certain foot deformities, reduced skin oxygenation 
and  foot  perfusion  ,poor  vision,  greater  body mass,  and  both  sensory  and  autonomic  neuropathy 
independently influence foot  ulcer  risk,  thereby providing support  for  a  multifactorial  etiology for 
diabetic foot ulceration.23 .In a prospective study Adler et al identified peripheral sensory neuropathy, 
PVD, foot ulcers (particularly if they appear on the same side as the eventual LEA), former amputation, 
and treatment with insulin as independent risk factors for LEA in patients with diabetes2. 
CLINICAL PRESENTATION OF FOOT ULCER
The most frequent presentation of the diabetic foot is the neuropathic ulcer. These ulcers appear 
as punched out and clean unless infected. Its classic position is under the metatarsal heads, heel and the 
tip of the toes 21.Ischemic ulcers arise at the margins of feet and have a ragged appearance; the foot is 
usually cold, with absent pulses. Infected ulcers show inflammatory signs of warmth, erythema and 
tenderness. Constant foul smelling discharge and crepitus is indicative of gas gangrene. Systemic signs 
of  fever,  leukocytosis  and  raised  levels  of  acute  phase  proteins  occur  when  the  patient  becomes 
septicemic but maybe absent when infection remains confined to the deep tissues 84.  
CLINICAL EXAMINATION AND SCREENING OF FEET AT RISK OF ULCERATION
Routine  examination  of  the  diabetic  feet  should  include  screening  for  risk  factors,  clinical 
inspection, neurological examination and vascular assessment. Clinical evaluation begins with a history 
of previous ulceration or amputation. Clinical examination includes inspection for foot deformities, 
limitation of joint mobility, osseous prominence secondary to Charcot arthropathy, areas of erythema 
and callus formation.
Neurological testing is done for identification of loss of protective sensation. The perception of 
pain, touch and vibration is done using pin prick, cotton wool and tuning fork. Other screening tests 
that  predict  ulceration  include  a  vibration  perception  threshold  (VPT)  >25v  (measured  using  a 
biothesiometer) and the inability of the patient to feel the 5.07 Semmes-Weinstein monofilament at the 
great toe or metatarsal head 3.
Vascular  assessment  includes  eliciting  history  for  claudication  and  the  palpation  of  lower 
extremity pulses. The absence of two or more foot pulses on palpation is widely used as a diagnostic 
criterion  for  peripheral  vascular  disease.  The  use  of  Doppler  ultrasound  is  a  useful  adjunct  for 
measurement  of  ankle  systolic  pulses.  An  ankle  –brachial  index  of  <0.813 is  taken  as  abnormal 
vascularity and <0.6 indicates significant arterial stenosis.     
CLASSIFICATION OF FOOT ULCERS
Numerous classification schemes have been proposed for describing diabetic foot ulcers. The 
most commonly used and most often referred to is the  Meggitt-Wagner system  which categorizes 
diabetic foot ulcers into five grades on the basis of anatomical location, depth and presence of ischemia 
74,81,84. 
MEGGITT-WAGNER CLASSIFICATION OF DIABETIC FOOT ULCERS
GRADE CONDITION
0 High risk foot, no ulcer
1 Superficial skin ulcer
2
Deep  ulcer  extending  through  dermis.Tendons,ligaments,joint 
capsule or bone may be exposed
3 Deep ulcer with abscess, osteomyelitis and joint sepsis
4 Localized gangrene of forefoot or heel
5 Gangrene of foot
Wagner Grade 0 describes a pre ulcerative or post ulcerative lesion. There is no break in the 
skin, but risk factors such as calluses or foot deformities are present. Grade 1 ulcers are superficial, full 
thickness ulcers with penetration past the dermis. They are indicative of the presence of peripheral 
sensory neuropathy along with at least one other risk factor for ulceration. Continued weight bearing on 
them will cause deepening of the foot ulcers past the dermis with involvement of deeper structures such 
as tendons, ligaments, joint capsules and neurovascular structures. These are the grade 2 ulcers and 
they do not  probe  to  the  bone.  Wagner  grade  3 ulcers  are  characterized  by the  presence  of  deep 
infection and bone involvement. Abscess formation or osteomyelitis is usually present. Grade 4 ulcers 
present with partial gangrene of the foot demonstrating extensive vascular insufficiency, sepsis and 
tissue  necrosis  which  necessitates  aggressive  management  for  limb  salvage.  Grade  5  ulcers  are 
characterized by extensive necrosis and gangrene which is best addressed by limb amputation. Though 
this system is easy to use it has its limitations in that it is not descriptive enough to allow for cross 
comparison of ulcers between different centers and misclassifies infective digital gangrene (grade 4, 
localized) which has little or no macrovascular disease84.  The criticisms include its failure to gauge the 
degree  of  ischemia  in  grade  1  to  3  and its  inability  to  address  the  combination  of  infection  and 
ischemia. Additionally, it does not provide predictions on healing and outcomes.
The other classification systems include the Nottingham system (UK); the University of Texas’ 
St.Antonio wound classification system 84,53,46  ,the International working group classification 20  and one 
by Brodsky and Lavery.  A study by Samson Oyibo et  al  compared the Wagner’s  system and the 
University of Texas ( UT )system and found the UT system (Appendix II) a better predictor of the 
healing time and outcome 64.A new scoring system called The DEPA scoring system which includes 
the depth of the ulcer (D), the extent of bacterial colonization (E), the phase of ulcer healing (P) and the 
associated underlying etiology(A)  has been studied .An increasing DEPA score was associated with 
increased risk of amputation and poor healing60 .
While  these  classification  systems  are  more  inclusive,  the  comprehensiveness  makes  them 
difficult to remember and use in the clinical setting. Hence the American Diabetic Association has 
formed a working committee to propose a new system74. 
MANAGEMENT
Treatment of diabetic foot varies greatly depending on the severity of the ulceration as well as 
the presence of ischemia. The cornerstone of treatment for full thickness ulcer consists of adequate 
debridement, off loading of pressure, treatment of infection and local wound care.
REMOVAL OF CALLUS : The callus that surrounds the ulcer must be removed by podiatry. 
Excess keratin must be pared away to expose the floor of the ulcer and allow efficient drainage and 
proper re-epithelisation.A simple non adhesive dressing should be applied after cleaning the ulcer. 
DEBRIDEMENT : The  treatment  of  choice  for  the  complete  removal  of  all  necrotic, 
dysvascular and non viable tissue is sharp, surgical debridement .Other debridement techniques are also 
available.Autolytic debridement refers to the body’s own mechanism of removing devitalized tissue 
done primarily by the macrophages. Enzymatic debridement involves the use of topical agents with 
ability to degrade necrotic tissue via proteolytic enzymes. Mechanical debridement gently loosens the 
slough and removes it from the wound bed. The simplest  form of this technique is the commonly 
applied wet to dry saline gauze. While this is an inexpensive and relatively easy method, it removes 
both viable and non viable tissue and causes pain in the sensate foot.
PRESSURE OFF LOADING: Reduction of pressure is essential in the healing of plantar foot 
ulcers. The most popular methods include total contact casting, half shoes, and short leg walkers and 
felt foam dressings.
ERADICATION OF INFECTION: A proper understanding of the pathogens involved in the 
foot  infection  is  required  before  instituting  antimicrobial  chemotherapy.  The  ulcer  culture  and 
sensitivity report is therefore imperative. The wound swab should be taken from the floor of the ulcer. 
Swab cultures usually grow out numerous surface contaminants and may not provide information on 
the pathogen(s) causing the deep tissue infection.30  .Two swabs should be collected, one for gram stain 
and the other for culture .A superficial ulcer may be treated on an outpatient basis and  oral antibiotics 
prescribed, according to the organism isolated. Cultures are most reliable when a deep tissue specimen 
is obtained. All organisms recovered from deep tissue cultures should be treated as pathogens unless 
there is evidence to support that the culture was contaminated from another source. 
Culture of material carefully collected from abscess cavities or by surgical biopsy of deep soft 
tissue  or  bone  provides  the  most  useful  guide  to  treatment  and  minimizes  the  potential  for 
contamination. Culture of material from sinus tracts is unreliable. 
Before an infected wound is cultured, care should be taken to remove any overlying necrotic 
debris from the site. Vigorously scrubbing the wound with saline-moistened sterile gauze43 often can 
accomplish this. Culture of the wound base, preferably from expressed pus, can then be attempted. 
Specimens obtained from curettage of the base of the ulcer correlate best with results from deep-tissue 
culture. 
Gram's stain is often helpful for interpreting culture results A surface culture may grow several 
organisms, while Gram's stain may reveal only a single bacterial morphology. 
The polymicrobial nature of most infections of the diabetic foot is well known, with an average 
of five or six organisms involved 43. A mixture of aerobic and anaerobic organisms is common. In one 
study,  anaerobic  organisms  were  recovered  from 90% of  cultures.  Foul-smelling  drainage  and the 
presence of gas in the tissues, detected by clinical or radiographic evaluation, often predict a mixed 
polymicrobial infection. Adequate coverage for these organisms is important. Some anaerobes will be 
killed by contact with molecular oxygen for only a few seconds. Specimens are to be collected from a 
prepared site using sterile technique. Overlying and adjacent areas must be carefully disinfected to 
eliminate contamination with indigenous flora. Ideally, pus or other fluid obtained by needle aspiration 
through intact skin or mucosal surface which has been cleaned with antiseptic should be collected. 
Sampling of open lesions is enhanced by deep aspiration using a sterile plastic catheter. If irrigation is 
necessary, nonbacteriostatic sterile normal saline may be used. Anaerobic transports must be used for 
swabs and for aspirates. Specimens for anaerobic culture should be maintained at room temperature. 
Under these conditions, aerobes and anaerobes will survive 24-72 hours when properly collected in the 
anaerobic transport tube 72.
OTHER LABORATORY MEASUREMENTS 
Total  count,  differential  count,  ESR,  plasma  glucose  levels,  HbA1C,  renal  parameters  and 
radiography  provide  information  regarding  the  infection  status  and  extent  of  involvement.  Bone 
detected by probing a pedal ulcer has a sensitivity of 66 percent for osteomyelitis and a specificity of 
85 percent  43. While standard radiographs may be of assistance in diagnosing osteomyelitis, MRI is 
considered the more sensitive and specific pathologic confirmation of osteomyelitis. Serial radiographs 
compared  with  baseline  radiographs  may be  of  significant  value  in  determining  progressive  bone 
changes resulting from osteomyelitis.
ANTIBIOTIC THERAPY:  Antimicrobial  selection  should take  into  account  the  causative 
organisms while bearing in mind the potential toxicity of the agents. In the diabetic foot, the bacteria 
mostly responsible for non limb threatening infection are staphylococci and streptococci, while limb 
threatening infections are the consequence of polymicrobial infection 50,59.
Empirical  antibiotic  selection  should  be  based  on  the  suspected  pathogen  along  with  the 
modifications  to  address  anticipated  resistant  pathogens  that  may have  been  selected  during  prior 
hospitalization. Broad spectrum antibiotics should be begun empirically with reassessment following 
the result of culture and sensitivities. The duration of antibiotic therapy should be based on the clinical 
response  and  wound  care.  Two  weeks  of  therapy  are  the  usual  guideline;  however,  recalcitrant 
infections may require longer courses. For treatment purposes, the ulcers are classified as non – limb 
threatening, limb threatening and life threatening.
CATEGORY ANTIMICROBIAL REGIMEN
NON-LIMB THREATENING Cephalexin 500mg p.o.q6h
Clindamycin 300 mg p.o.8h
Amoxicillin  Clavulanate  (875/125 
mg)1q12h
Dicloxacillin 500mg q6h
Levofloxacin 500-750mg qd
LIMB THREATENING Ceftriaxone 1g IV daily plus Clindamycin 
450-600 mg ivq8h
Ciprofloxacin  400mg  iv  q  12h  plus 
Clindamycin 450-600 mg ivq8h
Ampicillin/sulbactam3g iv 6h
Ticarcillin/clavulanate3g iv q4-6h
Piperacillin/tazobactam  3.375  g  q4h  or 
4.5g  iv q6h
Flouroquinolone  iv  plus  metronidazole 
500mg iv q8h 
LIFE THREATENING Imipenem cilastatin 500mg iv q6h
Piperacillin/tazobactam  4.5g  iv q6h plus 
Gentamicin 1.5mg/kg iv8h
Vancomycin  1g ivq12h plus  Gentamicin 
plus metronidazole
EMERGENCE OF ANTIMICROBIAL RESISTANCE
This is of prime concern today as widespread usage of antibiotics has led to emergence of novel 
resistance mechanisms among the microbes.  Among the Gram positive cocci  Methicillin  Resistant 
Staph Aureus (MRSA) and Vancomycin Resistant Enterococci (VRE) are highly dangerous.
The most serious resistance patterns now emerging among Gram-negative organisms include 
resistance to extended-spectrum cephalosporins and penicillins. This resistance is commonly mediated 
by ESBLs in  Escherichia coli and  Klebsiella species, or by the hyper production of chromosomally 
mediated cephalosporinases (Bush group I amp C enzymes) in  Citrobacter,  Serratia  and Citrobacter  
species. The ESBL genes generally result  from point mutations in the genes of broad-spectrum  β-
lactamase Ambler class A enzymes, such as TEM-1, TEM-2 or SHV-1. They are usually located in 
conjugative mega plasmids, which often carry genes responsible for resistance to other antibacterial 
drugs, making it extremely difficult to treat infections caused by bacteria that produce these enzymes. 
Along with ESBLs,  plasmid-mediated  Ambler  class  C cephalosporinases  (or  Bush group 1 
cephalosporinases) have been found in clinical isolates of the Enterobacteriaceae. These enzymes can 
produce resistance to cephamycins, extended spectrum cephalosporins and aztreonam, and unlike class 
A ESBLs, β-lactamase inhibitors do not inhibit these bacteria.
GLYCEMIC CONTROL
The concept that improved glycemic control could delay or prevent the appearance of micro 
vascular complications was studied by Jean Pirart and conclusively proven by the Diabetes Control and 
Complications trial75 and the UK Prospective Diabetes Study 76, respectively in 1993 and 1998.
WOUND CARE 
The effective use of dressing is essential to ensure the optimal management of diabetic foot 
ulcers.  A  clean,  moist  wound  healing  environment  prevents  tissue  dehydration  and  cell  death, 
accelerates angiogenesis and facilitates the interaction of growth factors with the target cells. Standard 
dressing care for the treatment of diabetic foot ulcers in the US is still the use of wet-to-dry or wet-to-
moist saline gauze dressings. Hutchinson, et al., studied the incidence of infection under occlusion and 
found it to be four times more likely to occur under dry gauze than under occlusion. High levels  of 
exudates warrant the choice of a moisture-absorbing material,  which may include alginates, foams, 
collagen-alginate  combinations,  carboxymethylcellulose  materials,  or  gauze.  Low  exudates  and 
desiccated wounds respond well to hydro gels. Occlusive hydrocolloids are not recommended over 
highly exuding wounds in weight-bearing areas.
ADVANCED WOUND CARE PRODUCTS
New biologic products and drugs directly interact with the wound environment to manipulate 
and direct activity at a cellular level. These include biological skin substitutes and recombinant PDGF. 
Skin Replacements
Cultured human keratinocytes have been developed and used in the past. They are of limited 
benefit on full-thickness defects and have not been shown to be of benefit in the treatment of diabetic 
foot ulcers.
Derma graft® is  a semi synthetic  material  composed of  human neonatal  dermal  fibroblasts 
cultured onto a bioabsorbable mesh. The metabolically active cells are responsible for the secretion of 
human dermal collagen, growth factors, and other proteins, which may contribute to wound closure. 
Dermagraft is FDA approved for use in the treatment of diabetic foot ulcers.
Apligraf® is a bilayered, allogeneic skin equivalent with a fully differentiated epidermis and a 
dermis.  The dermis  consists  of bovine collagen containing human fibroblasts  derived from human 
foreskins,  while  the  epidermis  is  derived  from  keratinocytes  also  attained  from  infant  foreskins. 
Apligraf is currently indicated for the treatment of venous ulcers and diabetic foot ulcers. 
Growth Factors
Becaplermin is recombinant human platelet-derived growth factors and is the only currently 
approved growth factor indicated for the use of diabetic neuropathic plantar foot ulcers. Becaplermin is 
a recombinant, dosed, and regulated product. While currently indicated and FDA approved for use on 
diabetic ulcers, becaplermin's mechanism of action is not specific to diabetic wounds. 
Prior to the introduction of becaplermin, the only available growth factor was an autologous, 
unregulated product called Procuren® Autologous materials, to date, are neither produced in regulated 
doses nor FDA controlled. 
Granulocyte colony–stimulating factor (G-CSF) is an endogenous hematopoietic growth factor 
that  induces  terminal  differentiation and  release  of  neutrophils  from  the  bone  marrow.  G-CSF 
stimulates the growth and improves the function of both normal and defective neutrophils, including in 
patients with diabetes and has immunomodulatory and antibiotic-enhancing functions. In its purified, 
cloned  recombinant  form,  commercially approved  G-CSF has  been  used  to  treat  various  difficult 
infectious problems. Because G-CSF specifically enhances neutrophil functions, several investigators 
have  explored  using  it  as  an  adjunct to  treating  diabetic foot infections.  In  a  metanalysis  study 
conducted by Lipsky et al adjunctive G-CSF treatment does not appear to hasten the clinical resolution 
of  diabetic foot infection or ulceration but is associated with a reduced rate of amputation and other 
surgical  procedures.  Treatment  with  G-CSF was  also associated with  a  tendency toward  a  shorter 
duration of parenteral antibiotic therapy 55.  
PREVENTION AND FOOT CARE
Many  diabetic  foot  ulcers  and  their  complications  can  be  avoided  by  simple  preventive 
measures.  It  has  been  estimated  that  upto  80% of  diabetic  foot  ulcers  are  preventable.  High-risk 
patients without ulceration should be examined every three months, while those with open wounds not 
requiring hospitalization should be seen at least once a week. Even people with diabetes at low risk for 
ulceration and amputation should have their feet examined on an annual basis, while moderate risk 
patients may be seen twice a year. The latter examination schedule would be considered appropriate 
care.
FOOTWEAR: Footwear is one of the most critically important components in preventing foot 
ulcer. Use of footwear with a thick insole , avoiding barefoot walking and use of open toed shoes or 
sandals, avoiding reuse of sweaty socks and  keeping the dry foot moist are some of the guidelines 
given by the American Diabetic Association 83.  
MATERIALS AND METHODS
This is a cross-sectional study conducted at the Institute of Microbiology at Madras Medical 
College, Chennai for a period of one year from December 2004 to December 2005.Samples of wound 
isolates taken from 104 patients with diabetic foot ulcer attending as outpatients in the Diabetology OP 
and those admitted in the surgical wards of the Diabetology Department were collected and processed. 
30 outpatients and 74 inpatients were included in the study.  
DISEASE DEFINITION 
Diabetic foot infection was defined as the presence of a non-healing wound with evidences of 
inflammation, with or without systemic toxicity, and with a definite growth on culture that correlated 
with the Gram’s stain result.
SELECTION CRITERIA  
Inclusion criteria
Male and female Diabetic patients in the age range of 20 to 90 having type 1 or type 2 diabetes 
and presenting with grade 1 to grade 5 foot ulcers were selected in the study. Each patient was included 
only once in the study.
Exclusion criteria 
Patients presenting with just callus and no foot ulcer (grade 0) were excluded from the study.  
CLINICAL ASSESSMENT
The patients were clinically assessed and history regarding the duration of diabetes, smoking, 
alcohol intake, trauma preceding the ulcer, previous history of ulcer or amputation ,duration of stay in 
the hospital, associated medical illnesses like ischemic heart disease or renal disease, glycemic control 
status, the use of OHA / insulin and antibiotics used were appraised. Physical examination included 
inspection of the foot ulcer and musculoskeletal examination for any foot deformity. The location, size, 
depth,  margin,  colour,  grade  of  the  ulcer,  presence  of  granulation  tissue,  necrotic  tissue,  edema, 
erythema, foul odour, and purulent discharge was noted. 
NEUROLOGICAL EXAMINATION
Neurological assessment for peripheral neuropathy was done using the 5.07 Semmes-Weinstein 
monofilament (SWM). The ability of the patient to feel the filament at the great toe and the metatarsal 
heads was recorded. Scoring was done as mild, moderate, or severe peripheral neuropathy.
VASCULAR ASSESSMENT
Vascular  assessment  was  done  by  palpation  of  all  lower  extremity  pulses  and  DOPPLER 
Examination (for inpatients) of the brachial, posterior tibial, popliteal, dorsalis pedis and anterior tibial 
arteries .Estimation of the ankle –brachial index was done. An ankle brachial index of <0.9 was taken 
as impaired vascularity.
ULCER GRADING
Ulcer  grading  was  done  using  the  Megitt  Wagner  Classification  of  diabetic  foot  ulcers. 
(Appendix III). 
SAMPLE COLLECTION 
The ulcer site and size were examined with the patient laying supine on an examination table. 
Superficial dead tissue was removed with sterile scissors and a scalpel blade. After local debridement 
of devitalized tissue, the ulcer wound was scrubbed thoroughly with normal saline to remove surface 
colonizers. Sample collection was then done by
a)  Using sterile cotton swabs for all cases 
b) Scrapings  of  the  ulcer  base  collected  in  a  sterile  manner  where  necrotic  tissue  was 
present
c) Pus aspirates where appropriate (presence of any deep abscess).
Wound swabs were taken from the base of the grade 1 ulcer. Two swabs were collected, one for 
Gram stain and the other for aerobic culture. For Grade 2 to Grade 5 ulcers, swabs and scrapings of the 
ulcer  base  were  taken.  Anaerobic  isolation  was  done  when  clinically  suspected  and  for  this  the 
overlying and adjacent areas were carefully disinfected with 70% ethanol to eliminate contamination 
with  indigenous  flora.  When  swabs  and  tissue  scrapings  were  collected  they  were  immediately 
inoculated into the transport media. In deep abscesses pus was obtained by needle aspiration, the tip of 
which was immediately plunged into a sterile rubber cork to prevent air exposure.
TRANSPORTATION OF SAMPLES
Samples were taken immediately to the laboratory .Specimens meant for anaerobic processing 
were transported in brain heart infusion broth in 0.1% agar base.
SAMPLE PROCESSSING CHART
Sample Collection
Swabs
Ulcer base scraping
Needle Aspiration
Blood for Culture
Macroscopic examination
- Odour
- Pus
- Pigment
- Blood
-Granules
Microscopic Examination
- Direct Gram stain
- KOH Mount
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Fungal
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Anaerobic
Culture
Aerobic
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Betalactamase
MIC for ceftazidime
ESBL
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Primary culture plates
1. BAP + Vit.K1 + Hemin+
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Nitrate reduction
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Non enteric BHI
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MACROSCOPIC EXAMINATION
The presence of blood, pus, foul odour, granules, or pigment was noted.
MICROSCOPIC EXAMINATION
The type and relative number of microorganisms and host cells was identified by a direct Gram 
stain smear of all the samples. (Appendix IV) The direct smears were fixed in methanol for 30 seconds 
instead of heat fixation so as to preserve the tissue cell and bacterial cell morphology.
DIRECT EXAMINATION FOR FUNGAL ELEMENTS
Samples collected using sterile swabs were examined with 10% KOH mount. Gram staining 
was performed to observe the presence of yeast and pseudohyphae.
ISOLATION OF ORGANISMS
AEROBIC CULTURE 
The specimens were cultured on Blood agar and MacConkey agar plates for aerobic culture 
.Incubation  was  done  at  370 C  for  24-48  hours.  The  bacterial  isolates  were  then  identified  and 
antimicrobial  sensitivity  performed by the  standard  microbiological  techniques  as  per  the  NCCLS 
guidelines 54.
ANAEROBIC CULTURE:
Anaerobic culture was done when clinically indicated by inoculation of specimens immediately 
on sampling into Robertson’s cooked meat broth and  brain heart infusion broth in 0.1% agar topped 
with paraffin wax (Appendix VII). The tubes were immediately overlaid with sterile liquid paraffin and 
transported to the lab without delay.  Level I  identification included information from the primary 
plates in conjunction with Gram stain and colony morphology.  Level II identification was based on 
colony and cell  morphology,  gram stain,  susceptibility to  antibiotic  identification discs  and nitrate 
reduction disc test.   The sample was inoculated onto the following freshly poured  primary culture 
plates 6. 
A) 5%sheep blood agar plates supplemented with vitamin k1 (10µg/ml) and Haemin (5µg/
ml) and Gentamicin 20 µg/ml. (Appendix VIII) 
B) Robertson’s cooked meat media. 
C) Bacteroides Bile Esculin Agar as the selective medium for identification of Bacteroides 
fragilis. (Appendix IX)
D) CAP incubated aerobically in 5-10% CO2 atmosphere in candle jar for aerotolerance 
check.
Incubation was done in  anaerobic  Macintosh and Fildes  jar  (the inlet  and outlet  closed)  at 
35-37ºC for 48 hours.  Gas pak was used as the reducing agent with palladianised asbestos as the 
catalyst. Reduced methylene blue was used as the indicator.24 
EXAMINATION OF PRIMARY PLATES AND SUBCULTURE 
Following incubation, the primary plates were examined for colony morphology, hemolysis and 
pigmentation. The individual colonies were identified by Gram stain and sub cultured to the following 
purity plate:
CDC Blood agar plates: (Appendix VIII) The following antibiotic discs were placed on the 
first  quadrant  of  the  purity  plate.Vancomycin  5µg,  Kanamycin  1000µg and  Colistin  sulphate10µg 
.Metronidazole 5µg discs and nitrate discs were placed in the second quadrant. The plates were then 
incubated anaerobically as mentioned above for 48 hours at 35ºC.
INTERPRETATION  OF  THE  ANTIBIOTIC  DISC  IDENTIFICATION  ON  THE  PURITY 
PLATES
The colony characteristics were noted. A Zone of 10 mm or less around the antibiotic discs 
indicated resistance and greater than 10 mm indicated susceptibility. A brown colour change of the 
nitrate on adding the nitrate test reagent indicated test positive for nitrate reduction.
FUNGAL CULTURE
Fungal isolates were identified by inoculation into Sabouraud’s dextrose agar35 and incubated at 
250C and 370C for 3-4 weeks before discarding .The slants were examined every day for the first week 
and then thrice a week subsequently. Fungal isolates grown were identified by gram stain. Candida 
species were tested for germ tube production  (Appendix V)
BLOOD CULTURE 
In patients with clinical signs of sepsis blood culture was performed .5-10 ml of blood was 
collected after  sterile precautions and inoculated into brain heart  infusion broth bottles.  After 6-18 
hours bacterial growth that appeared was sub cultured into NAP, 5 % sheep BAP and Mac Conkey 
Agar  plates.  The  colonies  grown  after  24  hrs  were  identified  by  the  standard  microbiological 
techniques. If no visible growth was seen in the broth, blind subculture was done at 24 hrs, 48 hrs and 1 
week. Anti microbial drug susceptibility was performed in Mueller Hinton agar by Kirby Bauer disc 
diffusion method.
I.  LEVEL II IDENTIFICATION OF ANAEROBES
Cell 
Shape
Spores Box Car 
Shaped 
Cells
Double zone 
βhemolysis
Kanamycin 
1 mg
Vanco 
mycin 
5µg
Colistin 10 
µg
Nitrate 
Reduction
Pits the 
Agar
Growth in 
20% bile 
Pigment Esculin 
Hydrolysis
Gram positive Cocci C,CB - - - V S R - - - - -
Peptostreptococcus 
anaerobius
C,CB - - - R S R - - - - -
Peptostreptococcus 
asaccharolyticus
C - - - S S R - - - - -
Clostridium Sp. B + - - V S R + - - - -
C.perfringens B - + + S S R + - - - -
C.baratii B + - - S S R V - - - -
C.sordeilli B + - - S S R - - - - -
C.bifermentans B + - - S S R - - - - -
Propionibacterium 
acnes
B,CB - - - V S R + - - - -
Eubacterium lentum B - - - S S R + - - - -
Bacteroides fragilis 
group
B NA NA NA R R R - - + - +
Bacteroides 
urealyticus gp
B NA NA NA S R S + + -
Fusobacterium  sp B NA NA NA S R S - v v - v
Veillonella sp C NA NA NA S R S + - - - -
V- variable S- Sensitive   R - Resistant     
B - Bacilli C - Coccobacilli NA - Not applicable
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ANTIMICROBIAL SUSCEPTILITY TESTS
Antibiotic  sensitivity was  performed on Mueller  Hinton  agar  plates  by the 
Kirby Bauer disc diffusion method using antibiotic discs obtained from HI MEDIA, 
Mumbai.  Standard  0.5  McFarland  saline  suspensions  of  bacteria  were  used  to 
inoculate the Mueller Hinton agar media confluently with a cotton swab. The resultant 
zones of inhibition were measured with a scale using transmitted light. (Appendix X)
GRAM POSITIVE COCCI
The antibiotics used for Gram positive organisms were
Penicillin G(10 U) ,Oxacillin (1µg),Erythromycin (25µg) , Ampicillin(10µg) , 
Ampicillin-Sulbactam  (10/10µg),  Ceftazidime  (30µg),  Cefaperazone  (75µg), 
Ofloxacin (5µg) and Vancomycin(30µg). 
GRAM NEGATIVE BACTERIA 
The antibiotics employed for Gram negative bacteria were
Amikacin(30µg),  Gentamicin(10µg),  Ofloxacin(5µg),  Ceftazidime 
(30µg),Cefaperazone  (30µg)  ,  Cefaperazone  – Sulbactam,   (75/30µg)   Pipericillin 
(100 µg ), Cotrimoxazole  (25µg)and Imipenem  (10µg) 
BETA LACTAMASE DETECTION
The  isolates  were  tested  for  β  lactamase  production  by  the  iodometric 
method82. (Appendix XI)
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MINIMUM INHIBITORY CONCENTRATION
The MIC is the lowest concentration of antibiotic which inhibits the growth of 
the bacterium. MIC50 of all isolates for Ceftazidime was put up according to the agar 
dilution method. (Appendix XII)
DETECTION  OF  EXTENDED  SPECTRUM  BETA  LACTAMASE 
PRODUCTION (ESBL) AND AmpC
Two methods were employed to detect ESBL production. Forty seven isolates 
of Gram-negative bacteria exhibited resistance to Ceftazidime (30µg disc) under the 
disc diffusion method. A zone size <18 mm was interpreted as resistance or decreased 
susceptibility (intermediate  by NCCLS criteria).As per the NCCLS guidelines any 
isolate showing a zone of inhibition <22 mm or an MIC <=2µg/ml for Ceftazidime 
should be tested  for ESBL.Thus fifty four isolates which met this criteria were tested 
for ESBL.
Screening for ESBL and AmpC beta lactamases
We simultaneously tested for ESBL and AmpC beta lactamases by a modified 
double disc synergy test (DDST) 71.
Modified Double Disk Synergy Test (DDST)
A lawn culture of test strain on Mueller Hinton agar was exposed to disc of 
Ceftazidime (30 µg) and a disc of amoxiclav (augmentin) (20 µg amoxicillin/10 µg 
clavulanic  acid)  arranged  in  pairs.  The  discs  were  arranged  so  that  the  distance 
between them was approximately twice the radius of the inhibition zone produced by 
Ceftazidime tested on its own. A cefoxitin (30µg) disc was also placed at a distance of 
20mm from the Ceftazidime disc. The test isolate was considered to produce ESBL, if 
the  zone  size  around  the  antibiotic  disc  increased  towards  the  Augmentin  disc. 
Isolates showing reduced susceptibility to Ceftazidime  and cefoxitin or blunting of 
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the Ceftazidime  adjacent to the cefoxitin disc were considered as screen positive for 
AmpC.
Combined Disc Method
In  the  combined  disc  method  (CDM),  we  used  a  modified  procedure  of 
NCCLS  procedure, in  that  a  Cefaperazone  disc  (75  µg)  and  a  Cefaperazone–
Sulbactam disc (75–30µg) were used.  A  5 mm increase in  zone diameter  for the 
Cefaperazone–Sulbactam disc versus  the  Cefaperazone  disc  was  interpreted  as 
production of ESBL. 
Controls: Known ESBL positive and negative strains were used as the controls.  The 
result of the DDST method  was taken for interpretation.
CONFIRMATORY METHOD FOR AmpC BETA LACTAMASES
AmpC DISC  TEST:  All  the  fifty  four  isolates  were  checked  for  AmpC 
production  by  the  AmpC  disc  test.  A  lawn  culture  of  ATCC  E.coli  25922  was 
prepared on MHA plate. Sterile disc (6mm) were moistened with sterile saline (20µl) 
and inoculated with several colonies of the test organism. The inoculated disk was 
then  placed  beside  a  cefoxitin  disc  (30µg)  almost  touching  it.  The  plates  were 
incubated at 35oC overnight.
INTERPRETATION: A flattening or indentation of the cefoxitin inhibition 
zone for ATCC E.coli in the vicinity of the test disc was interpreted as a positive test. 
An undistorted zone was taken as negative test.     
STATISTICAL ANALYSIS
Chi-square test was used for the statistical analysis of the result.
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RESULTS
TABLE 1
SEX DISTRIBUTION
MALES FEMALES
63 (60.57%) 41 (39.42%)
N = 104
Males were more commonly affected. Male: female ratio =1.53:1
TABLE 2
AGE DISTRIBUTION
AGE RANGE
NO.OF PATIENTS 
=104
% of patients
20-30 3 2.88
31-40 14 13.46
41-50 17 16.34
51-60 46 44.23
61-70 17 16.34
71-80 6 5.77
81-90 1 0.96
N= 104
The age ranges of the patients varied from 25 to 82 years.
Majority (44.23%) of the patients were in the 51-60 age group.
Mean age of patients = 54.93. (Standard deviation = 10.926)
                                  
TABLE 3
FOOT INVOLVEMENT
FOOT  INVOLVED N=104 %
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Right 65 62.5
Left 37 35.57
Bilateral 2 1.92
Right foot (62.5%) was more involved than the left.       
TABLE 4
GRADE OF ULCERS
GRADE N=104 %
                1                13                  12.5
                2                16                  15.38
                3                30                  28.84
                4                42                  40.38
                5                 3                    2.88
                                       
Majority of the patients had Grade 4 ulcers. (40.38%)
Since ours is a tertiary care hospital catering to the poor socioeconomic 
group,  patients  presented  with  the  advanced  stage  of  the  disease  more 
frequently.
36
TABLE 5
TYPE OF DIABETES
TYPE OF 
DIABETES
N=104 %
TYPE 1 7 6.73
TYPE 2 97 93.26
Patients were predominantly suffering from type 2 diabetes (93.26%).
TABLE 6
THE DURATION OF DIABETES MELLITUS
DURATION OF 
ILLNESS(YEARS) N %
<1 3 2.88
1-5 36 34.61
6-10 44 42.30
11-15 5 4.80
16-20 3 2.88
Not  Known(Diag  At  Time 
Ofadmission)
13 12.5
Duration of diabetes mellitus was another important risk factor and it 
varied from as less as 4 months to 17 years. 
Thirteen of them were diagnosed as diabetic only on admission.
Most (42.30%) of the patients had DM for 6-10 years. 
TABLE 7
 ASSESSMENT OF RISK FACTORS FOR FOOT ULCER
RISK FACTORS N=104 %
Smoker 32 30.76
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Alcoholic 24 23.07
Trauma 35 33.65
Previous ulcer 16 15.38
Prior amputation 6 5.76
Previous  ulcer  leading  to 
amputation
9 8.65
Trauma (33.65%) and smoking  (30.76%) were  the  most  common risk 
factors, followed by alcohol intake and previous ulcer.
None of the risk factors assessed were significant ( p value >0.05) for the 
development of foot ulcer.
TABLE 8
DISTRIBUTION OF PATIENTS WITH NEUROPATHY
NEUROPATHY N=104 %
Mild 39 37.5
Moderate 29 27.88
Severe 2 1.92
No neuropathy 34 32.69
N=104.
Neuropathy  was  seen  in  67.30%  of  patients.  Most  of  them  had  Mild 
neuropathy  (37.5%).Neuropathy  was  significant  for  the  development  of  foot 
ulcer. (p <0.05)
TABLE 9
VASCULAR ASSESSMENT
VASCULAR ASSESSMENT N=74 %
Ischemic 9 12.16
Neuroischemic 18 24.32
Normal vascularity 41 55.40
N=74.Vascular assessment using Doppler was done for the in-patients.
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Impaired vascularity was seen in 27 patients.  (25.96%)
Nine  patients  (12.16%)  had  purely  ischemic  while  18  (24.32%)  had 
neuro-ischemic ulcers.
TABLE 10
ASSOCIATED MEDICAL DISEASES
ASSOCIATED MEDICAL 
DISEASE
N
% of total 
patients
Coronary heart disease 8 7.69
Hypertension 8 7.69
Renal dysfunction 5 4.80
The morbidity  of  the  disease  is  increased  by  other  associated  medical 
illnesses.
Coronary heart disease and hypertension were present in eight patients 
each, while renal dysfunction was present in  5 patients.
TABLE 11
 DAYS OF STAY IN HOSPITAL
DURATION OF STAY IN 
HOSPITAL(DAYS)
N=74 %
1-5 10 13.51
6-10 38 51.35
11-15 16 21.62
16-20 5 6.75
21-25 3 4.05
26-30 2 2.70
N= 74 (No. of inpatients)
More than half of the hospitalized patients (51.35%) required a stay of  
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6-10 days. 
TABLE 12
NO.AND (%) OF PATIENTS WHO WENT
FOR AMPUTATION
AMPUTATION N %
AK 3 2.88
BK 10 9.61
Toe disarticulation / 
Ray amputation
20 19.23
33 patients (31.73%) underwent amputation.
Nearly  20%  of  the  subjects  had  minor  (toe  disarticulation  /Ray 
amputation) amputation done.
TABLE 13 
THE CLINICALPROFILE OF PERSONS WITH AND WITHOUT 
AMPUTATION DUE TO DIABETIC FOOT ULCERS
Clinical 
characteristic
s
Total
Patients who 
underwent 
amputation(33)
Patients 
without 
amputation 
(71)
N S.D. N S.D. N S.D.
P value
Mean 
duration  of 
diabetes
7.14 3.71 8.33 3.75 6.37 3.43 N.D57;p<0.05
Mean RBS 190.88 46.1 192.69 58.20 189.07 34
S.E of 
mean 
=0.332 
p>.05
Medications N % N % N %
OHA 42 40.38 18 42.85 24 57.14 p>.05
Insulin 26 25 16 61.53 10 38.46 p>.05
Fever 7 6.73 5 71.42 2 28.57
Leukocytosis 3 2.88 3 100% 0 0
Blood culture 3 2.88 3 100% 0 0
Wagner’s 
grade
40
1 13 12.5 0 0 13 12.5
2 16 15.38 0 0 16 15.38
3 30 28.84 5 4.80 25 24.03
4 42 40.38 25 24.03 17 16.34 P<0.05
5 3 2.88 3 2.88 0 0 P<0.05
SD = Standard Deviation;
SE = Standard Error of Mean
ND = Normal Deviate
Mean duration of diabetes was slightly more among amputees (8.33) than 
non amputees (6.37).
Only  68(65.38%)  patients  were  on  medications-OHA  (40.38%)  and 
insulin (25%).
The  average  blood  glucose  level  was  190.88  indicating  poor  glycemic 
control.
7 patients had fever of whom 3 had leukocytosis;  all 3 were blood culture 
positive and underwent amputation.
Amputation rate increased with grade of foot ulcer; 59.52% of grade 4 
ulcer and 100% of pts with grade 5 ulcer underwent amputation.
TABLE 14
 AEROBIC ORGANISMS ISOLATED
IN  WOUND CULTURE
Aerobic 
Isolates
N % of aerobic isolates (n=138)
% of total 
isolates (n=169)
GPC 
Staphylococcus aureus 21 15.21 12.43
Enterococcus faecalis 8 5.79 4.73
TOTAL 29 21.01 17.16
GNB
Escherichia coli 25 18.11 14.79
Klebsiella pneumonia 13 9.42 7.69
Klebsiella oxytoca 1 0.72 0.43
Citrobacter koseri 1 0.72 0.43
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Proteus vulgaris 5 3.62 2.96
Proteus mirabilis 36 26.08 21.30
Proteus penneri 1 0.72 0.43
Morganella morganii 9 6.52 5.33
Ac. baumanii 1 0.72 0.43
Pseudomonas aeruginosa 17 12.32 10.06
TOTAL 109 78.98 81.66
GNBs (78.98%) were isolated more than the GPCs (21.01%).
Proteus mirabilis was the commonest isolate (26.08%).
Staphylococcus aureus was the commonest GPC isolate (15.21%).
The ratio of GNB: GPC=3.75:1.
TABLE 15 
ANAEROBIC ORGANISMS ISOLATED
IN WOUND CULTURE
Anaerobic Isolates N % of anaerobic isolates
% of total 
isolates
Bacteroides fragilis 8 32 4.73
Peptococcus sp. 8 32 4.73
Peptostreptococcus sp. 5 20 2.95
Clostridium welchii 3 12 1.77
Clostridium tetani 1 4 0.59
Total 25 100 14.79
Anaerobes constituted 14.79% of the total isolates.
Bacteroides fragilis and Peptococcus sp. were the common anaerobes 
obtained.
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Cl.tetani  was  isolated  from  a  patient  with  grade  3  ulcer;  no  toxic 
symptoms were observed.
TABLE 16
FUNGAL ORGANISMS GROWN
IN WOUND CULTURE
Fungal Isolates N % of fungal isolates % of total isolates
Candida albicans 5 83.33 2.96
Non – albicans Candida sp. 1 16.67 0.59
Total 6 100 3.55
Fungal organisms comprised only 3.55%of the total isolates. 
Among the fungi Candida albicans was the commonest fungal pathogen 
(83.33%).
TABLE 17
CORRELATION OF BLOOD CULTURE
RESULTS AND WOUND CULTURE RESULTS
Organisms 
isolated in 
blood culture
Organisms isolated in 
wound culture
Grade of 
ulcer
Amputation
E.coli E.coli,P.mirabilis,
B.fragilis
5 AK
E.coli E.coli,P.mirabilis, 4 Forefoot 
amputation
S.aureus S.aureus,E.coli, 
Peptostrep.
5 AK
Blood Culture was done in 7 patients who presented with fever. 
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Among them 3 were culture positive.3 isolates  were obtained- E.coli=2 
and S.aureus =1.
The isolates  were the same as  the  organisms obtained in  wound swab 
culture. Two of them had grade 5 ulcer and underwent AK amputation while 
one patient had grade 4 ulcer and had forefoot amputation done. 
TABLE 18
COMPARISON OF MONOMICROBIAL AND
POLYMICROBIAL ISOLATES IN PATIENTS
WITH AND WITHOUT AMPUTATION
Microbial 
Profile
With amputation 
n=33
Without 
amputation n=71
Total n=104
Monomicrobial 9 (27.27%) 31(43.66%) 40(38.46%)
GPC 3 9 12(11.53%)
GNB 6 22 28(26.92%)
Polymicrobial 22(66.66%) 37(52.11%) 59(56.73%)
GPC + GNB 2 4 6(5.76%)
>=2 GNBs 12 7 19(18.26%)
>=2 GPC 1 2 3(2.88%)
GPC/GNB+Anae
robe
6 19 25(24.03%)
Gpc/gnb+fungi 1 5 6(5.76%)
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No growth 2(6.06%) 3(4.22%) 5(4.80%)
Anaerobes 6 19 25(24.03%)
Fungi 1 5 6(5.76%)
More than half of the cases (56.73%) had polymicrobial infection.
The  combination  of  aerobe  (GPC/GNB)  +Anaerobe  constituted  nearly 
half of the polymicrobial group. (24.03%)
The ratio of Polymicrobial: Monomicrobial infection was 3:2.In amputees 
it was 2.4:1 while in the non amputees group it was 1.2:1
Anaerobic and fungal organisms always occurred in mixed infection. 
No growth was seen in 5 cases.
TABLE  19
COMPARISON OF MICROBIAL PROFILE BETWEEN
IN-PATIENTS AND OUT-PATIENTS
Microbial Profile Outpatients(30) In patients (74) % (N=104)
Monomicrobial 23(76.66%) 17(22.97%) 40(38.46%)
GPC 10 2 12(11.53%)
GNB 12 16 28(26.92%)
Polymicrobial 4(13.33%) 55(74.32%) 59(56.73%)
GPC + GNB 1 5 6(5.76%)
>=2 GNBs 2 17 19(18.26%)
>=2 GPC 0 3 3(2.88%)
GPC/GNB+Anaerobe 1 24 25(24.03%)
Gpc/gnb+fungi 0 6 6(5.76%)
No growth 3(10%) 2(2.7%) 5(4.80%)
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Monomicrobial infection was seen more among out-patients (76.66%).
In hospitalized patients, infections were often polymicrobial (74.32%).
Majority  of  the  anaerobic  (24/25)  and  all  fungal  infections  were  seen 
among hospitalized patients.
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TABLE 20
ISOLATION OF AEROBIC AND ANAEROBIC BACTERIAL
ORGANISMS FROM DIFFERENT GRADES OF FOOT ULCERS
Gram 
positive cocci 
n=29
Gram negative 
bacilli n=109
Anaerobes 
n=25
Total n=163
NO % NO % NO % NO %
Grade 1 7 24.13 15 13.76 0 0 22 13.49
Grade 2 3 10.34 16 14.67 0 0 19 11.65
Grade 3 7 24.13 24 22.01 5 20 36 22.08
Grade 4 11 37.93 50 45.87 14 56 75 46.01
Grade 5 1 3.44 4 3.66 6 24 11 6.74
N=163 29 17.79 109 66.87 25 15.33 163 100
Gram negative bacilli were predominant in all the grade of foot ulcers. 
Maximum (46.01%) isolates were obtained from grade 4 ulcers.
Isolation of Anaerobic organisms increased with the grade of foot ulcers.
GPC were found in higher % in grade 1 ulcer.  They formed 34% of the 
total isolates in Grade 1 ulcer and were found in < 20% of the total isolate in the 
other grades of foot ulcer.
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TABLE 21.ANTIMICROBIAL SENSITIVITY PATTERN FOR GRAM POSITIVE COCCI.
All the gram positive isolates were 100% sensitive to Vancomycin  and 100% resistant to penicillin ; they were less sensitive to 
Ampicillin and Erythromycin. In addition poor sensitivity to Gentamicin was seen among Enterococcus faecalis.
Ampicillin - sulbactam was effective in all Methicillin Sensitive Staph aureus (MSSA) and Enterococci sp. 
Staph aureus exhibited moderate sensitivity to Ceftazidime, Cefaperazone and Ampicillin - sulbactam (76.19%)  while 
enterococcus faecalis was 75% sensitive to both Ceftazidime and Amikacin.
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Table 22
  BETA LACTAMASE PRODUCTION
Gram Positive Cocci
Beta Lactamase 
producers
%
Staph.aureus (21) 12 57.14
Enterococcus faecalis (8) 2 25
Total (29) 14 48.27
Beta  lactamases  were  detected  among  the  GPCs  by  the  iodometric 
method and constituted 48.27%. 
Staph.aureus  had  a  moderate  degree  of  beta  lactamase  production 
(57.14%).
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TABLE 23
ANTIBIOTIC SENSITIVITY PATTERN OF
GRAM NEGATIVE BACILLI
GRAM 
NEGATIVE 
BACILLI
Ak G Of Ca Cs Cfs Pc Co I
No. % No % No % No % No % No % No % No % No %
E. coli  (  n= 25 ) 21 84 10 40 6 24 15 60 7 24 22 88 10 40 2 8 25 100
K.pneumoniae 
( n=13  )
11 84.6
1
9 69.2
3
11 84.6
1
10 76.9
2
8 61.5
3
12 92.3
0
9 69.23 1 7.69 13 100
K.  oxytoca   (n= 
1 )
1 100 0 0 1 100 0 0 0 0 1 100 1 100 0 0 1 100
C.koseri  (n= 1 ) 1 100 1 100 1 100 0 0 0 0 1 100 1 100 0 0 1 100
Pr.mirabilis(n=36
)
17 47.2
2
7 19.4
4
14 38.8
8
12 33.3
3
6 16.6
6
32 88.8
8
7 19.44 6 16.6
6
36 100
Pr.vulgaris (n= 5 ) 3 60 1 20 3 60 3 60 2 40 5 100 1 20 0 0 5 100
Pr.penneri (n= 1 ) 1 100 0 0 0 0 0 0 1 100 1 100 0 0 0 0 1 100
M.morganii  (n= 
9 )
5 55.5
5
2 22.2
2
6 66.6
6
6 66.6
6
4 44.4
4
8 98.6
9
2 22.22 2 22.2
2
9 100
Ps.aeruginosa  
(n= 17)
9 52.9
4
5 35.2
9
10 58.8
2
9 52.9
4
9 52.9
4
15 88.2
3
15 88.23 1 5.88 17 100
Ac.baumannii 0 0 0 0 0 0 0 0 0 0 1 100 0 0 0 0 1 100
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( n= 1 )
All the Gram negative bacilli were 100% sensitive to Imipenem and around 90% sensitive to Cefaperazone - Sulbactam
E.coli was moderately sensitive to Amikacin (84%).
Klebsiella spp. were moderately  sensitive to Amikacin and Ofloxacin (84.61% each).
Only one isolate of Citrobacter spp was isolated and it was sensitive to Amikacin, Ofloxacin and Gentamicin.
Proteus species exhibited moderate to poor sensitivity to all the drugs.
Pseudomonas spp was highly sensitive to Pipericillin but poorly sensitive to all the other antimicrobials.
Acinetobacter sp. was resistant to all drugs except Imipenem and Cefaperazone - Sulbactam.      
All the isolates were poorly sensitive to Cotrimoxazole.  
Multidrug resistance (>3 drugs) was observed in 28.26% of isolates. E.coli-9,   Klebsiella spp-7, Proteus species -15,   Pseudomonas 
spp-4, Morganella sp-3 and Acinetobacter sp.-1.
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TABLE 24
RESISTANCE OF GNBS TO THIRD GENERATION CEPHALOSPORINS
Organisms Ceftazidime Resistant
Isolates (zone size<18mm)
No. of isolates with MIC 
>=2µg/ml
E.coli (25) 7 (28%) 10 (40%)
Kleb.pneumoniae (13) 5 (38.46%) 6 (46.15%)
Kleb.oxytoca (1) 1 (100%) 1 (100%)
Citrobacter koseri (1) 1 (100%) 1 (100%)
Proteus mirabilis (36) 22 (61.11%) 24 (66.66%)
Proteus vulgaris (5) 2 (40%) 2(40%)
Proteus penneri (1) 1 (100%) 1(100%)
M. morganii (9) 2 (22.22%) 3 (33.33%)
Ps.aeruginosa (17) 5 (29.41%) 5(29.41%)
Ac.baumanii (1) 1 (100%) 1(100%)
Total 109 47 (43.11%) 54(49.54%)
Forty  seven isolates  exhibited  resistance  to  Ceftazidime phenotypically  (zone  size 
<18mm) and Fifty four isolates had MIC greater than 2µg/ml.
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TABLE 25
MINIMUM INHIBITORY CONCENTRATION OF CEFTAZIDIME
Organisms 64µg/ml 128µg/ml 256µg/ml Total MIC50 MIC90
E.coli 2 7 1 10 128µg/ml 128µg/ml
Kleb.pneumoniae 1 4 1 6 128µg/ml 128µg/ml
Kleb.oxytoca 0 1 0 1 128µg/ml 128µg/ml
Citrobacter koseri 0 1 0 1 128µg/ml 128µg/ml
Proteus mirabilis 5 15 4 24 128µg/ml 256µg/ml
Proteus vulgaris 1 1 0 2 64 µg/ml 128µg/ml
Proteus penneri 0 1 0 1 128µg/ml 128µg/ml
M. morganii 0 1 2 3 256µg/ml 256µg/ml
Ps.aeruginosa 0 1 4 5 256µg/ml 256µg/ml
Ac.baumanii 0 0 1 1 256µg/ml 256µg/ml
TOTAL 9 32 13 54
All the members of Enterobacteriaceae had an MIC50 of 128 µg/ml except for Proteus 
vulgaris (64µg/ml).
 Morganella sp. and the non-fermenter GNBs, Pseudomonas sp. and Acinetobacter 
sp.had a higher MIC50 of 256µg/ml.
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TABLE 26
NO. AND % OF ESBL PRODUCERS
Organisms
No of Ceftazidime  resistant 
isolates
Total
No. of isolates with 
ESBL phenotype
DDST CDM
% of ESBL 
producers 
among CAZ. 
resistance 
isolates
% of ESBL 
producers 
among total 
isolates
E.coli (25) 10 6 6 60% 24%
K.spp.(14) 7 5 5 71.42% 30.76%
C. koseri(1) 1 0 0 0% 0%
P. mirabilis(36) 24 14 17 58.33% 38.88%
P. vulgaris(5) 2 1 1 50% 20%
P. penneri(1) 1 0 1 0% 0%
M. morganii(9) 3 2 2 66.66% 22.22%
Ps.aerug (17) 5 2 3 40% 11.76%
Ac.baumanii(1) 1 0 1 0% 0%
Total 109 54 30 36 55.55% 27.52%
The results of the Modified Double Disc Synergy Test was taken for interpretation.
In addition to E.coli and Klebsiella pneumoniae, ESBL detection  was performed for 
other enterobacteriaceae also.
55.55% of the Ceftazidime resistance was due to ESBL production.
The % of ESBL among the total isolates was 27.52%.
Proteus mirabilis (38.88%) was the commonest organism exhibiting ESBL followed 
by Klebsiella sp (30.76%).24% of E.coli strains were ESBL producers.
The  combined  disc  method  using  Cefaperazone-Sulbactam  gave  a  better 
identification of ESBLs.
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TABLE 27
NO.AND % OF AmpC PRODUCERS
Organisms
No of CAZ resistant isolates
Total
AmpC
Phenotype 
screening 
test 
positive
AmpC 
confirmato
ry test 
positive
% of AmpC 
producers 
among CAZ. 
resistance 
isolates
% of AmpC 
producers 
among total 
isolates
E.coli (25) 10 4 4 40 2.89
K.spp.(14) 7 2 1 14.28 7.14
C. koseri(1) 1 1 1 100 100
P. mirabilis(36) 24 14 8 33.33 22.22
P. vulgaris(5) 2 1 1 50 20
P. penneri(1) 1 1 1 100 100
M. morganii(9) 3 3 1 33.33 11.11
Ps.aerug (17) 5 2 1 20 7.24
Ac.baumanii(1) 1 1 1 100 100
Total 109 54 29 19 35.18 17.43
Screening for AmpC was positive in 53.70 of Ceftazidime resistant isolates. (29/54)
AmpC  production  was  seen  in  19  isolates  (35.18%)  that  exhibited  Ceftazidime 
resistance. They constituted 17.43% of the total isolates.
Only  one  isolate  each  of  Acinetobacter,  Citrobacter  and  Proteus  penneri  were 
obtained  and  all  were  AmpC  producers.E.coli  showed  significant  (40%)  AmpC 
production. 
No mechanism of cephalosporin resistance was explainable for 5 isolates.
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DISCUSSION
Foot ulcer is one of the most feared complications in persons with diabetes. The 
problem gets  compounded  with  infection  causing  considerable  distress  to  the  patient. 
Their quality of life is severely deteriorated. It is one of the most common precursors to 
lower extremity amputation, thereby affecting the mobility of the patients and increasing 
their morbidity. This study was done to analyse the risk factors for foot ulceration and 
amputation,  to  understand  the  microbial  agents  involved  in  the  infection  and  their 
antimicrobial resistance pattern so that an effective antibiotic regimen can be employed to 
curtail the infection at the earliest.
The demographic profile of our patients showed that males (60.57%) were more 
commonly  affected  than  females  (39.42%)  and  the  male  -  female  ratio  was  1.53:1  
(Table 1).  This  is  probably attributable  to the greater  out door activity of males   and 
thereby increased predisposition to trauma. In a study conducted in Delhi by Dhanwal 18 
and colleagues the male: female ratio was as high as 9:1.
Majority of our patients were in the fifty to sixty age groups (44.23%) (Table 2). 
The  mean  age  was  54.93.  93.26% of  our  patients  had  type  2  diabetes  (Table  5).  A 
multicenter  prospective trial  done by Morbach and Vishwanathan et  al57 to  assess  the 
regional differences in risk factors at Germany, Tanzania and Chennai had also shown that 
diabetic foot ulcer patients were predominately male and had Type 2 diabetes and the 
corresponding patient ages were 71, 56 and 51 years respectively.
The right foot (62.5%) was more affected than the left (35.57%) in our population 
with a ratio of 1.75:1 (Table 3). Faiz ur Rehman et al 26 in their study also had found that 
diabetic foot affected the right foot (64.7%) more commonly than the left foot (35.3%), in 
57
a ratio of 1.8:1.They had reasoned out that the right foot was the dominant foot and hence 
more prone for trauma.
The characteristic of the wound in the foot ulcer is another poignant feature that 
influences prognosis.  Majority of our patients  had grade 4 ulcers.  (40.38%) (Table 4). 
Margolis  et  al  14 in their  study found that the risk factors that  most dramatically were 
associated with a wound failing to heal were increasing wound size,  increasing wound 
duration, and the grade of the wound.
Duration of diabetes mellitus of our study group varied from as less as 4 months to 
17 years (Table 6). Thirteen of the patients were diagnosed only on admission while most 
of them were diabetic for 6-10 years. In our study the mean duration of diabetes was 7.18 
years while it was 6.6 years in a study by Raymundo et al.55  Morbach and Vishwanathan 
et al57 showed that the average diabetes duration until the onset of the initial foot lesion 
was 14 years in Germany and 12 years in India, but only 5 years in Tanzania.
Numerous  studies  have  been  done  to  find  out  the  risk  factors  associated  with 
diabetic foot. In the analysis of risk factors and precipitating causes for foot ulceration in 
diabetes, the present study showed the following findings. Trauma (33.65%) and smoking 
(30.76%) were the most common risk factors though their significance was not established 
(p  value>0.05)  (Table  7).  Past  history  of  foot  ulcer  (15.38%),  previous  amputation 
(5.76%) and alcohol intake (23.07%) were also not significant.
 Neuropathic  sign  was  present  in  67.30% of  the  study  population  and  was  a 
significant risk factor (Table 8). Mild neuropathic affliction was predominant (37.5%). 
Reiber29 and colleagues have indicated that Neuropathy was the most common component 
cause leading to ulceration. His study showed neuropathic changes in 78% followed by a 
minor traumatic event (77%) and ischemia in 35% that contributed to the development of 
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foot ulcers. In our study 25.96% of the subjects had impaired vascularity (Table 9). Nine 
patients (12.16%) had purely ischemic while 18 (24.32%) had neuro-ischemic ulcers. A 
study by Samson Oyibo et al64 also showed that only 1.0% was ischemic while 67.0% of 
the ulcers were neuropathic, 26.3% were neuroischemic.
The morbidity of the disease is increased by other associated medical illnesses. 
Eight patients each had coronary heart disease and hypertension. Renal dysfunction was 
present  in  5  patients  (Table 10).  More than half  of  the hospitalized patients  (51.35%) 
required a stay of 6-10 days (Table 11). 
Following  foot  infection,  amputation  is  the  most  dreaded  complication.  Thirty 
three (31.73%) patients underwent amputation of whom three had Above Knee amputation 
done (Table 12). Below knee amputation was done in 10 patients-(grade 3=2, grade 4=7, 
grade5=1) of whom two had bilateral foot ulcers. Great toe disarticulation/transmetatarsal 
amputation  was  performed  in  twenty  patients.  (grade3=4,  grade4=16).  Among  the 
amputees, nine (27.27%) gave history of previous ulcer and six of them had undergone 
prior amputation. Adler et al2 had reported in a prospective study that former amputation 
and  treatment  with  insulin  are  independent  risk  factors  for  amputation  apart  from 
peripheral sensory neuropathy and peripheral vascular disease.
In our study mean duration of diabetes was slightly more among amputees (8.33) 
than non amputees (6.37) (Table 13).  Only 68(65.38%) patients were on medications-
OHA (40.38%) and insulin (25%).The study showed that increasing grade of ulcer had an 
adverse effect on the wound resolution. Amputation rate increased with the grade of ulcer. 
All the patients who went in for amputation had > grade 3 ulcers. 59.52% of patients with 
grade 4 ulcers and all patients with grade 5 ulcer underwent amputation. Raymundo et 
al’s55 study revealed that the chief risk factors leading to limb amputation among patients 
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admitted for infected diabetic foot were duration of diabetes of more than 10 years and, 
advanced Wagner’s grade of foot ulceration on admission.
Poor glycemic control was another common feature in our patients who had an 
average plasma glucose level of 190.88 (Table 13). A study by Reiber et al 28 showed that 
the outcome of diabetic foot ulcer is related to poor glycemic control and longer diabetes 
duration. This point is further stressed in a study by Lavery et al47 that revealed an elevated 
glucose  level  (Glycated  haemoglobin  HbA1C  >9  %)  as  one  of  the  risk  factors  for 
ulceration.26 patients (25%) were insulin dependent and 42 patients (40.38%) were on 
oral  hypoglycemic agents.13 patients  were diagnosed only on admission.  The rest  (23 
patients 22.01%) were not on any medications.
Many of  the  studies  on the risk factors  have  conflicting  results.  In  the Seattle 
Diabetic Foot Study by Boyko et al, diabetes duration and type, smoking  status, and also 
other  factors like race,  education,  joint  mobility,  hallux blood pressure,  and other  foot 
deformities were found to be unrelated to foot ulcer risk in multivariate models 23.
Various methodologies have been tried by different workers for optimal sampling 
of infected diabetic ulcers. Most of the studies show deep tissue sampling by curettage of 
the  ulcer  base  /needle  aspiration  and  collection  of  the  tissue  or  bone  at  the  time  of 
debridement  to  be  superior  to  routine  surface  sampling.  The  yield  of  anaerobes  has 
substantially increased by these methods and risk of surface contamination is also reduced. 
In a study by Uday Kelkar and Anju et al77 the yield of aerobic and anaerobic organisms 
from diabetic foot ulcers, significantly more organisms were isolated from deep tissue 
samples (average 3.7 organisms per sample) than from properly collected swabs (150; 
average 3.0 organisms per sample ) indicating that deep tissue sampling is a more sensitive 
method. Kessler  et  al  had recommended needle aspiration for deep direct  sampling in 
diabetic  patients  with osteomyelitis  related to  foot  ulcer  when surgical  debridement  is 
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contraindicated or delayed  41. In the present study we used swabs, deep tissue scrapings 
and needle aspiration of abscesses.
The microbiology of diabetic lower extremity infection varies depending on the 
patient population studied. In this study the isolation rate of gram negative bacteria was 
higher compared to the gram positive cocci depicting a ratio of 3.75:1 .An average of 
1.629 organisms were isolated per specimen. Sharp et al69 had in their study obtained an 
average of 2.3 organisms per specimen among patients. Sapico67 et al had a high isolation 
rate with a mean of 4.7 bacterial species per specimen. In our study, aerobes constituted 
81.6% while anaerobes comprised of 14.79%of the total. In Unachukwu’s study 78 aerobes 
and anaerobes constituted 95.4% and 4.6% of the total bacterial isolates respectively. In a 
study by Sharp et al69 the anaerobic isolation rate was 27%. Bartlett et al 52 in their study 
showed a high isolation rate  of anaerobes.  There were a total  of 116 isolates with an 
average of 5.8 species per specimen (3.2 aerobes and 2.6 anaerobes).
 In  our  study GPC were 21.01% and GNBs were 78.98% of  the  total  aerobic 
isolates(Table 14). The ratio of GNB: GPC was 3.75:1. Staphylococcus aureus has been 
the  most  common  isolate  in  numerous  studies1,  26,  31,  40,  78.Though  not  the  commonest 
organism, a significant number of Staph.aureus (12.43%) have been isolated in our study. 
Several  reasons  could  be given,  56% of  the subjects  had received antibiotics  prior  to 
admission primarily oral cloxacillin or amoxicillin, which could have eradicated the gram-
positive organisms in the initially mixed infected lesions.
The  predominant  organisms  isolated  in  our  study  were  Proteus  mirabilis, 
Escherichia  coli,  Staph.aureus,  Pseudomonas  aeruginosa,  Klebsiella  pneumoniae, 
Morganella morganii and Enterococci in that order. Proteus mirabilis was the commonest 
isolate (26.08%) and Staphylococcus aureus was the commonest GPC isolate (15.21%). 
Similar  bacterial  isolates  were  found  by  Sharp  et  al  whose  study  had  Proteus  sp., 
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Enterococcus spp, Staphylococcus aureus, and other Enterobacteriaceae in that order. (63) 
In  Carvallho’s  study9 also  the  most  frequently  occurring  pathogens  were 
Enterobacteriaceae  (83.7%),  Staphylococcus  aureus  (43.3%)  and  anaerobic  bacteria 
(17%).
We isolated 25 anaerobes in culture of which Bacteroides fragilis and Peptococcus 
spp were the common organisms (Table 15).  Other isolates include Peptostreptcoccus sp. 
(5), Clostridium welchii (3) and Clostridium tetani (1). The principal anaerobes isolated by 
Bartlett and colleagues also were Bacteroides species , Peptococcus sp. and Clostridia sp. 
Wheat et al reported that most infections were heavily mixed; Common anaerobic isolates 
in  his  study  included  Peptostreptococcus  magnus,  Peptostreptococcus  prevotii,  and 
Bacteroides species. GPAC, cultured from 36% of specimens, were the major anaerobic 
group in their study82.  All the anaerobes were 100% sensitive to metronidazole in our 
study. We found that BHI with 0.1% agar gave a better isolation rate of the anaerobes 
compared to RCM. The competency to isolate all the species of anaerobic organisms was 
not yet maximized as of present time; therefore the low isolation rate of anaerobes. Fungal 
organisms  comprised  only  3.55%  of  the  total  isolates.  Candida  albicans  was  the 
commonest isolate (83.33%) (Table 16) In a study by Chincholikar et al, Candida albicans 
was the commonest fungal pathogen.
Seven patients presented with systemic signs of fever of whom three were blood 
culture positive.All 3 of them had higher grade of ulcer and underwent amputation (Table 
17). This showed that systemic toxicity occured in the advanced stage of the infection and 
was associated with an increased rate of amputation.
Among the amputees the isolation rate was higher.  More than half of the cases 
(56.73%) had polymicrobial infection.The combination of aerobe (GPC/GNB) +Anaerobe 
constituted nearly half of the polymicrobial group. (24.03%) The ratio of Polymicrobial: 
62
Monomicrobial  infection was 3:2.In amputees  it  was 2.4:1 while  in  the non amputees 
group it was 1.2:1. Scher and Steele68 in their study on amputation showed that infections 
among  amputees  were  polymicrobial,  with  5.8  bacterial  isolates  and  2.3  anaerobes 
recovered per patient (Table 18).
Monomicrobial  infection  was  seen  more  among  out-patients  (76.66%).Among 
hospitalized patients, infections were often polymicrobial (74.32%) comprising of aerobic 
gram-positive and gram negative organisms, as well  as obligate anaerobes (Table 19). 
Anaerobic  (24/25  isolates)  and  fungal  infection   was  also  seen  predominantly  among 
hospitalized patients only. Most of these patients had limb threatening infection. Boyko 
and  Lipsky22 have  in  their  work  noted  that  among  diabetic  outpatients  with  lower 
extremity infection aerobic gram-positive cocci were isolated as the sole pathogen in 42% 
of cases, while anaerobes and aerobic gram-negative bacilli were infrequently recovered. 
Thus, infection severity appears related to number and type of infecting organism. 
While studying the variation in the type of organisms in different grade of foot 
ulcers our work showed that Gram negative bacilli were predominant in all the grade of 
foot ulcers. Maximum (45.87%) isolation was seen in grade 4 ulcers. Anaerobic isolation 
rate also increased with grade of the ulcer  (Table 20).
Regarding the antimicrobial sensitivity pattern, we found that Staph. aureus was 
relatively better  sensitive to  Ceftazidime,  Cefaperazone  and Oxacillin  to  which  it  was 
moderately sensitive (76.19% each) (Table 21).  57.14% were beta lactamase producers 
and 5 of the 21 isolates were MRSA (23.80%). In a prospective study done by Goldstein et 
al  31 to analyze the microbial culture and sensitivity pattern,  Staphylococcus aureus  was 
the  most  common  isolate  (76% of  patients),  including  methicillin-resistant  S.  aureus 
(MRSA) in 5 of 25 (20%) patient wounds. An investigation by Tentolouris et. Al 73, among 
outpatients  reported  that  S.  aureus was  the  most  prevalent  pathogen  of  gram-positive 
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aerobes isolated from wounds and MRSA organisms comprised 40 percent of  S. aureus 
isolates. They reasoned that the high prevalence of MRSA in patients with foot ulcers may 
reflect the increased prevalence of MRSA in the community. They also found that MRSA 
infection or colonization was not associated with factors like previous hospitalization, use 
of antibiotics, etc that are known to predispose to  MRSA colonization or infection. For 
patients with a documented MRSA or those who are at high risk for MRSA, linezolid is 
becoming the  drug  of  choice. Sharpe  69  found that  linezolid  was not  only superior  to 
vancomycin  but  also  noted  there  were  seven  amputations  in  the  patients  treated  with 
vancomycin and none in the patients treated with linezolid. In our study all the isolates 
were sensitive to vancomycin.  57.14% of Staph aureus were beta lactamase producers 
(Table 22).
Enterococcus faecalis was moderately sensitive to CA and Ak (75% each). Both 
Staph.aureus and Enterococcus faecalis were 100% resistant to penicillin while they were 
100% sensitive to Vancomycin.  Ampicillin - sulbactam was effective in all MSSA and 
enterococci.
The sensitivity pattern of the Gram negative isolates revealed 100% sensitivity to 
Imipenem and around 90% sensitivity to Cefaperazone-Sulbactam (Table 23).  Kavitha et 
al39 had demonstrated the antimicrobial sensitivity pattern in diabetic foot ulcers. Their 
study showed sensitivity of the Enterobacteriaceae and non-fermenters to Cefaperazone + 
Sulbactam (78.4%)  and  Meropenem (97.8%).In  our  study the  Enterobacteriaceae  was 
better  sensitive  to  Amikacin  and  Ofloxacin  than  the  third  generation  cephalosporins. 
While Citrobacter spp was100% sensitive to Amikacin, E.coli and Klebsiella spp showed 
a sensitivity of 84% and 84.61% respectively to Amikacin. Klebsiella spp. was equally 
sensitive to Ofloxacin (84.61%).Proteus species exhibited moderate to poor sensitivity to 
all the drugs. A study by Anandi et al had also shown that E.coli (97%), and Klebsiella spp 
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(94%) were sensitive to Ciprofloxacin and Ofloxacin and all aerobes were sensitive to 
Amikacin.4  Pseudomonas spp was highly sensitive to Pipericillin and poorly sensitive to 
all the other antibiotics. Acinetobacter sp. was resistant to all drugs except Imipenem. All 
the isolates were poorly sensitive to Cotrimoxazole (<25%).
Multi  drug  resistance  was  seen  in  28.26%  of  the  organisms  predominantly 
occurring  in  Acinetobacter  sp(100%),  Klebsiella  sp(50%)  and  Proteus  species 
(41.66%).All the patients had >  grade 3 ulcers. In a study conducted by Hartemann et al, 
it was found that MDROs are often present in severe diabetic foot wounds. They found 
that about one-third of patients with a history of previous hospitalization for the same 
wound, and 25% of patients with osteomyelitis had MDRO-positive specimens 32.
Ceftazidime resistance was seen in 47 isolates phenotypically and the MIC of 54 
isolates was greater than 2µg/ml (Table 24). All the members of Enterobacteriaceae had an 
MIC 50 of 128 µg/ml except for Proteus vulgaris (64µg/ml).Morganella sp. and the  non-
fermenter GNBs, Pseudomonas sp. and Acinetobacter sp. had a higher MIC50 of 256µg/ml 
(Table 25).
Resistance to third generation cephalosporins due to acquisition and expression of 
Extended Spectrum β-lactamase (ESBL) enzymes among Gram-negative bacteria are on 
the increase. Presence of ESBL producing organisms has been reported to significantly 
affect the course and outcome of an infection. In our study we employed two methods, the 
modified  double  disc  approximation  method  using  Ceftazidime  and  amoxiclav  and 
combined  disc  method  using  Cefaperazone  alone  and  Cefaperazone  –Sulbactam disc. 
(Table 26)
Cefoperazone/sulbactam  (1:1)  is  a  unique  combination  of  III  generation 
cephalosporin that  is  more stable  to  b-lactamases  then penicillins with inhibitor  at  the 
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highest  available  ratio.  Among  all  b-lactam-inhibitor  combinations  tested 
Cefoperazone/sulbactam  revealed the highest activity against ESBL-producing organisms. 
Its superior activity is probably attributed to the improved stability of Cefaperazone and to 
the high concentration of the inhibitor component- Sulbactam. 19. 
We found that the combined disc method was more effective in the detection of 
ESBL producers.ESBL production  was observed in  28.84% of  the  study subjects  and 
55.55% of the Ceftazidime resistant strains. The % of ESBL among the total isolates was 
27.52%.  The  pattern  observed  in  our  study  was  E.coli  24%,  Klebsiella  spp.30.76%, 
Proteus  mirabilis  38.88% and  no  ESBL production  in  Citrobacter  spp.  In  a  study by 
Raghavendra  Rao  et  al63,  ESBL production  was  observed  in  10.6% of  E.coli,10% of 
Klebsiella,9.3% of Proteus and 5.1% of Citrobacter spp. In Carvallho’s study 9 the ESBL 
producing strains were detected only in 6% of the patients. Gargritu and Gulati et al27 had 
employed  Cefaperazone  and  Cefaperazone-Sulbactam  for  the  detection  of  ESBL 
production. Their study showed ESBL production among Pseudomonas strains as high as 
61.25%.
The  other  resistance  mechanism  that  we  simultaneously  screened  for  while 
detecting ESBL production was the presence of AmpC beta lactamases (Table 27). The 
presumptive AmpC producers were later  confirmed by the AmpC disc method .AmpC 
production was seen in 19 isolates (35.18%) that exhibited Ceftazidime resistance and they 
constituted  17.43%  of  the  total  isolates.E.coli  showed  significant  AmpC  production 
(40%).No mechanism of  cephalosporin  resistance  was  explainable  for  5  isolates.  In  a 
study by Singhal et al the AmpC production was seen in 8% of the gram negative clinical 
isolates. Kenneth Thomson had in his work reported that high-level expression of AmpC 
may prevent  recognition of an ESBL40,  especially in  species  or strains  that  produce a 
chromosomally  encoded  inducible  AmpC  beta-lactamase  (e.g.,  Enterobacter,  Serratia, 
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Providencia, Aeromonas spp., M. morganii, C. freundii, Hafnia alvei, and P. aeruginosa). 
With these organisms, clavulanate may act as an inducer of high-level AmpC production 
while Tazobactam and Sulbactam are much less likely to induce AmpC beta-lactamases 
and are therefore preferable inhibitors for ESBL detection tests with these organisms.
In  many  hospitals,  beta-lactam/beta-lactamase  inhibitor  compounds,  such  as 
piperacillin/tazobactam  or  ampicillin/sulbactam,  are  considered  first  line  therapy  for 
complicated diabetic foot infections. These drugs have a spectrum of activity that consists 
of excellent gram positive and anaerobic coverage with variable activity against the gram 
negatives. We have proposed the following empiric antibiotic regimen according to the 
Wagner grades of foot ulcers.
• For Grade 1 and Grade 2 ulcers oral Cephalosporins /Cloxacillin can be 
given for GPCs and oral quinolones like Ciprofloxacin and Ofloxacin can 
be given for GNBs. Parenteral  aminoglycoside + cephalosporins can be 
used for enterococcal infections.
• In  Grade  3  and  Grade  4  ulcers,  GPCs  can  be  empirically  treated  with 
Ampicillin  –Sulbactam;  Cefaperazone  +  Sulbactam  along  with 
Metronidazole IV will cater for the GNBs and anaerobic organisms.
• For  Grade  5  ulcer,  Vancomycin  /Imipenem +Metronidazole  IV  can  be 
employed.
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SUMMARY
• Males (60.57%) were more affected than females (39.42%).
• Majority of the patients affected were in the 51- 60 years age group. The mean age of 
the patients was 54.93.
• Significant risk factors for ulceration include neuropathy and longer mean duration of 
diabetes mellitus .Other factors like smoking, trauma, previous ulceration and alcohol 
intake were not contributory in the development of foot ulcer.
• Significant risk factor for amputation was polymicrobial infection and increased grade 
of ulcer.
• Diabetic  foot  disease  causes  significant  morbidity  as  the  average  duration  of 
hospitalization in more than half the patients (51.35%) was 6-10 days.
• Associated co-morbid conditions included coronary heart  disease,  hypertension and 
renal dysfunction though the presence of these had no effect on the course of the foot 
ulcer.
• Amputation was the main complication.31.73% of the patients were amputated; AK 
amputation in 3, BK amputation in 10 and forefoot amputation in 20 patients.
• Aerobic (81.66%), anaerobic (14.79%) and fungal (3.55%) isolates were obtained on 
culture.
• Among the aerobes GNB (78.98%) were isolated more than the GPC (21.01%).
• Proteus mirabilis (26.08%) was the commonest isolate.
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• Staph. aureus (15.21%) was the commonest GPC isolate.
• Among  the  anaerobes  Bacteroides  fragilis  and  Peptococcus  sp.were  the  common 
isolates. (32% each).
• Candida albicans was the commonest fungal isolate. (5 of 6 fungal organisms).
• Blood culture  was  positive in  3  patients.  All  three  underwent  amputation and had 
higher  grade of  foot  ulcer.  (grade 5=2,  grade 4=1).This  indicated  that  the risk for 
sepsis  increases  with  the  grade  of  foot  ulcer  and  in  that  eventuality  chances  of 
amputation also went up.
• Polymicrobial infection was present in 56.73% of the cases.74.32% of the hospitalized 
patients had polymicrobial infection. Their rate was higher among amputees.
• Anaerobic (24/25 isolates) and all fungal infections  were seen among hospitalized 
patients only.
• Anaerobic isolation rate increased with the grade of foot ulcer.
• All the GPC were sensitive to Vancomycin.  Ampicillin-Sulbactam was effective for 
all MSSA and enterococci sp. All the GNBs exhibited 100% sensitivity to Imipenem 
and around 90%  sensitivity to Cefaperazone-Sulbactam.
• Beta lactamases  were detected  in  48.27% of  the GPCs by the iodometric  method. 
57.14% of Staph.aureus strains were beta-lactamase producers.
• MRSA constituted 23% of the Staph. aureus recovered.
• The  Gram  positive  cocci  were  better  sensitive  to  Cephalosporins  and  Oxacillin. 
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Enterobacteriaceae  were  better  sensitive  to  Amikacin  and Ofloxacin  than  the  third 
generation Cephalosporins. Pseudomonas sp was highly sensitive to Pipericillin.
• Multi Drug Resistance was seen in 28.26% of the aerobic isolates.
• Resistance to third generation Cephalosporins was seen in 39.13% of gram negative 
isolates.
• All the members of Enterobacteriaceae had an MIC50 of 128 µg/ml for Ceftazidime 
except for Proteus vulgaris (64µg/ml). Morganella sp. and the non-fermenter GNBs 
Pseudomonas sp. and Acinetobacter sp.had a higher MIC50 of 256µg/ml.
• ESBL  production  was  observed  in  28.84%  of  the  total  GNBS  and  55.55%  of 
Ceftazidime  resistant  isolates. Proteus  mirabilis  (38.88%)  was  the  commonest 
organism exhibiting ESBL followed by Klebsiella sp (30.76%).24% of E.coli strains 
were ESBL producers. The detection of ESBL was better observed by the combined 
disc method using Cefaperazone and Cefaperazone-Sulbactam combination.
• AmpC producers  comprised of  (35.18%) that  exhibited  Ceftazidime resistance and 
they constituted 17.43% of the total isolates.
• The mechanism of cephalosporin resistance was not clear in 5 isolates.
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CONCLUSION
The study revealed that
• Peripheral neuropathy and longer duration of diabetes are the factors that predispose to 
foot ulcers while polymicrobial infection and increasing grade of foot ulcer aggravated 
the chance of amputation.
• The  most  common microorganisms  were  gram-negative  aerobes,  and  the  isolation 
pattern,  according  to  the  grade  of  ulcer  was  primarily  Staphylococcus  aureus  in 
Wagner I diabetic foot.  Gram-negative organisms, majority of which were  Proteus  
mirabilis  sp. and Escherichia coli sp.,  were isolated as the foot grade advanced to 
gangrene. Significant anaerobic growth was observed in Wagner’s IV and V lesions.
• Management  of  early  stages  include  treatment  with  oral  quinolones  /  cloxacillin  / 
Cephalosporins.  Ampicillin- Sulbactam and  Cefaperazone-Sulbactam were found to 
be very effective drugs. Imipenem monotherapy or third-generation Cephalosporins 
with beta lactamase inhibitors plus an anti-anaerobe drug are attractive regimens for 
the advanced stage of the disease.
RECOMMENDATIONS:
• Patient education on prevention of foot ulceration and increasing their awareness on 
early management of a non healing wound is pivotal in reducing the incidence of the 
foot disease.
• Once admitted, patients with diabetic foot infections should be managed aggressively 
with  regular  wound  care  and  if  necessary,  repeated  debridement  to  prevent  the 
progression of infection to deeper tissues and subsequent development of gangrene.
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• Culture  and  sensitivity  results  should  be  followed  up  as  early  as  possible  and 
antimicrobial coverage should be adjusted accordingly. A polymicrobial growth and 
presence of anaerobes should be aggressively managed.
• Appropriate  and  timely  surgical  procedure  with  the  administration  of  the  correct 
antimicrobials based on the culture and sensitivity results is  still  the dictum in the 
successful management of diabetic foot infection.
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APPENDIX 
I. PROFORMA OF STUDY
NAME :
AGE :
SEX :
OCCUPATION :
ADDRESS :
OP / IP  NO :
PRESENTING COMPLAINT :
DURATION OF DIABETES :
ON INSULIN / OHA :
H/O NUMBNESS / TINGLING SENSATION / PAIN / PARAESTHESIA
:
SMOKER / ALCOHOLIC / HYPERTENSIVE
IF INPATIENT - NUMBER OF DAYS IN HOSPITAL :
PREVIOUS HISTORY OF FOOT ULCER / ANY CHRONIC NON - 
HEALING INFECTION :
OTHER ASSOCIATED DIABETIC ILLNESSES :
LOCAL TRAUMA / ANY PRECIPITATING CAUSE FOR FOOT ULCER :
TYPE OF FOOTWEAR :
FAMILY HISTORY OF DIABETES :
GENERAL EXAMINATION
BUILD / NOURISHMENT - WELL NOURISHED / ILL NOURISHED
LOCAL EXAMINATION
FOOT ULCER
SIZE
DEPTH
EDGE
ANY BLEEDING
BONE & JOINT INVOLVEMENT
SENSATION
TYPE OF DRESSING
ANY SURGICAL INTERVENTION :
GRADING OF ULCER :
ASSESSMENT OF OTHER FOOT :
NEUROLOGICAL ASSESSMENT :
ASSESSMENT OF VASCULARITY :
INVESTIGATIONS
TEMPERATURE :
TC :
DC :
ESR :
BLOOD UREA :
BLOOD SUGAR :
[F] :
[PP] :
[R] :
URINE SUGAR :
HBA1C :
SERUM ELECTROLYTES:
SERUM CREATININE
MICROBIAL STUDY : PUS  C/S
BLOOD CULTURE IF PATIENT IS FEBRILE
TREATMENT
ANTIBIOTICS
ANTIDIABETICS
OTHERS
OTHERS SYSTEMS
CVS
RS
ABDOMEN
CNS
ENDOCRINES
RENAL
OPHTHALMIC
ABBREVIATIONS USED IN THE TEXT
ABI                                           ANKLE BRACHIAL INDEX
AK AMPUTATION                 ABOVE KNEE AMPUTATION
BAP                                           BLOOD AGAR PLATE
BK AMPUTATION                  BELOW KNEE AMPUTATION
BL                                              BETA LACTAMASE
CAP                                           CHOCOLATE AGAR PLATE
CDC                                           CENTER FOR DISEASE CONTROL
DDST                                         DOUBLE DISC SYNERGY TEST
ESBL                                          EXTENDED SPECTRUM BETA LACTAMASE
G-CSF                                        GRANULOCYTE COLONY STIMULATING 
    FACTOR
GNB                                           GRAM NEGATIVE BACILLI
GPAC                                         GRAM POSITIVE ANAEROBIC COCCI
GPC                                           GRAM POSITIVE COCCI
KOH                                          POTASSIUM HYDROXIDE
LCB                                           LACTOPHENOL COTTON BLUE
LEA                                           LOWER EXTREMITY AMPUTATION
Mac                                            MAC CONKEY AGAR PLATE
MDRO                                       MULTI DRUG RESISTANT ORGANISMS
MIC                                           MINIMUM INHIBITORY CONCENTRATION
NAP                                           NUTRIENT AGAR PLATE
NCCLS                                     NATIONAL CENTRE FOR CLINICAL AND 
                                                  LABORATORY STANDARDS 
OHA                                          ORAL HYPOGLYCEMIC AGENT
PVD                                           PERIPHERAL VASCULAR DISEASE
RBS                                           RANDOM BLOOD SUGAR
RCM   ROBERTSON'S COOKED MEAT MEDIUM 
II) UNIVERSITY OF TEXAS FOOT ULCERATION CLASSIFICATION
 
STAGE GRADE0 1 2 3
A Pre or post 
lesion, intact
Superficial 
ulcer
Penetrating to 
tendon or joint 
capsule
Penetrating 
to bone or 
joint space
B +Infection +Infection +Infection +Infection
C +Ischemia +Ischemia +Ischemia +Ischemia
D +Infection and 
Ischemia
+Infection and 
Ischemia
+Infection and 
Ischemia
+Infection 
and 
Ischemia
III) MEGGIT AND WAGNER GRADING OF FOOT ULCER
GRADE CONDITION
0 High risk foot, no ulcer
1 Superficial skin ulcer
2 Deep ulcer extending through dermis.Tendons,ligaments,joint 
capsule or bone may be exposed
3 Deep ulcer with abscess, osteomyelitis and joint sepsis
4 Localized gangrene of forefoot or heel
5 Gangrene of foot
 IV) GRAM STAIN
REQUIREMENTS:
1. METHYL VIOLET -0.5-2%
2. GRAM’S IODINE
3. ACETONE DECOLORISER
4. DILUTE CARBOL FUCHSIN
PROCEDURE:
1. For direct gram stain the smear is fixed with methanol for 30 seconds as the 
cell morphology is better preserved .For culture smears heat fixation can be 
done.
2. The slide is then covered with the primary stain, methyl violet for one minute. 
Wash the slide with water.
3. Cover the whole slide with Gram’s iodine and leave for a minute .Wash the 
slide with water.
4. Decolourise with acetone as follows: Hold the slide with a forceps at a steep 
slope and pour acetone over the slide allowing it to act for 2-3 seconds. End 
decolourisation by removing all acetone in the stream of water from the tap.
5. Counterstain the smear with Dilute Carbol Fuchsin and allow it to act for 30 
seconds.
6. Wash thoroughly with water from tap and blot dry, placing the smear upwards.
7. Completely dry the slide in warm air by passing high above the Bunsen flame.
8. Observe the smear under oil immersion objective.  
V) GERM TUBE TEST
1. Lightly touch a single colony with a loop; remove the excess inoculum and 
then emulsify the yeast cells in 0.5 ml serum in a simple test tube.
2. Incubate  at  37ºC in  a  water  bath  for  2-4 hrs.  Prolonged incubation  is  not 
required.
3. A  loopful  is  then  taken  and  observed  under  coverslip  under  low  power 
microscope. Germ tube appears as extension of the yeast cells and gives a 
drum stick appearance. 
  
VI) HAEMIN AND MENADIONE FOR ANAEROBIC ISOLATION
HAEMIN 500 µg /ml: Dissolve haematin hydrochloride 50 mg in 1ml of 1 mol/litre 
NaOH solution and make up to 100 ml with distilled water. Filter sterilize.
MENADIONE 100 µg /ml:  Dissolve 10mg menadione in 2 ml ethanol and make 
upto 10ml with distilled water. Filter sterilize .Protect from light.
 The final concentration in the medium should be Haemin 5 µg /ml and menadione 
1µg /ml. For 100 ml media, 1ml each is added.
VII) BRAIN HEART INFUSION AGAR SEMISOLID MEDIUM
CONTENTS  
Calf Brain Infusion         - 200 g/l
Beef heart infusion         -  250 g/l
Proteose peptone            - 10 g
NaCl                               - 5 g/l
Disodium phosphate      - 2.5 g
Dextrose                        - 2.0 g
Sodium Polyanethol
Sulphate                         - 0.5 g
Agar                               - 1g/l
Dissolve 37.5 g in 1 litre distilled water. Heat well to ensure complete dissolution. 
Dispense into tubes and sterilize by autoclaving at 121ºC for 15 minutes. .1 g/l agar 
added  to  ensure  anaerobic  growth.  Final  pH adjusted  to  7.4.  The  tubes  are  then 
immediately sealed at their mouth using cotton wool plug soaked in molten sterile 
paraffin wax.
VIII) CDC BLOOD AGAR
CONTENTS
Trypticase soy agar - 15 g
Phytone                   -  5 g
NaCl                        - 5 g
Agar                         - 20 g
Yeast Extract          - 5 g
Haemin                   - 5 g
Vitamin K               - 400 mg
Deionised water      - 1 litre.
Sheep/ Rabbit blood -  50 ml.
METHOD
The basic medium except Haemin and Vitamin K is dissolved in 1 liter water 
and autoclaved at 121ºC for 20 minutes. The medium is then cooled to about 50ºC, 
when Haemin, Vitamin K and 5% sheep blood is added. The final concentration in the 
medium should be Haemin 5 µg /ml and menadione 1µg /ml.
IX) BACTEROIDES BILE ESCULIN AGAR
CONTENTS              g/l
Peptic digest         - 5  
Beef extract          - 3
Oxgall                   - 20
Esculin                  - 0.5
Ferric citrate         - 0.25
Agar                     - 15
METHOD
Dissolve 64.5g of the medium in 1 litre distilled water. Boil to dissolve the 
medium completely. Sterilize by autoclaving at 121ºC for 15 minutes.
X) SYMBOL AND STRENGTH OF THE ANTIBIOTICS USED AND THEIR 
ZONE SIZE INTERPRETATION CHART.
ANTIBIOTIC SYMBOL
STRENGTH 
(µg)
RESISTANT 
(mm)
INTERMEDIATE 
(mm)
SENSITIVE 
(mm)
AMIKACIN Ak 30 14 15-16 17
AMPICILLIN+SULBACTAM As 10/10 11 12-14 15
AMPICILLIN (Staph.aureus) A 10 28 - 29
CEFAPERAZONE Cs 75 15 16-20 21
CEFAPERAZONE+SULBACTAM Cfs 75/30 15 16-20 21
CEFTAZIDIME Ca 30 14 15-17 18
CIPROFLOXACIN Cf 5 15 16-20 21
COTRIMOXAZOLE Co 25 10 11-15 16
ERYTHROMYCIN E 15 13 14-22 23
GENTAMICIN G 10 12 13-14 15
IMIPENEM I 10 13 14-15 16
OFLOXACIN Of 5 12 13-15 16
OXACILLIN OX 1 10 11-12 13
PENICILLIN P 1O U 28 - 29
PIPERICILLIN Pc 100 17 - 18
PIPERICILLIN WHEN TESTING 
ENTERIC GRAM NEGATIVE 
BACILLI
Pc 100 17 18-20 21
VANCOMYCIN Va 30 - - 15
XI) BETA – LACTAMASE DETECTION
Iodometric method:
Requirements:
a) 1%soluble starch solution-prepared by dissolving the starch at 100ºC.
b) Iodine reagent-consisting of 2.03 g iodine and 5.32 g potassium iodide in 100 
ml distilled water. 
c) Micro titer plate.
Method: 
From an overnight culture of the test organism, a heavy suspension was made 
containing  10  9cfu/ml.  in  100 mM sodium phosphate  buffer  at  pH 7.3 containing 
penicillin at 6 g/litre.A negative control was put up without the test organisms. An 
organism known to produce β lactamase was put up as positive control. The test and 
the control organisms were then inoculated into the micro titer plate and incubated for 
one hour at 37ºC .1% soluble starch solution was then added to each well. A drop of 
the iodine reagent was then added. Loss of blue colour within 10 minutes was inferred 
as production of β-lactamase.
XII) DETECTION OF MINIMUM INHIBITORY CONCENTRATION
AGAR DILUTION METHOD
REQUIREMENTS:
a) Mueller Hinton Agar broth
b) Petri plates 
c) Ceftazidime powder reconstituted with distilled water.
d) Test strains
Procedure:
Medium: Mueller Hinton agar was heated at 100ºC and dispensed as 19 ml each in 
tubes, autoclaved and allowed to cool in a 50ºC water bath. 
Antibiotic:  The  Ceftazidime  powder  was  dissolved  in  Saturated  NaHCO3 and 
sterile water. Serial dilutions of the antibiotic from 256mg/l to 2mg/l were then made 
in the Mueller Hinton Broth at ten times the final concentration of the antibiotic in the 
plate. One ml of the antibiotic was added to 9ml of the medium. After adding the 
antibiotic the medium was mixed well  and poured into Petri  dish. A control plate 
containing the test medium without the antibiotic was prepared for each series of the 
dilution.
Test inoculum: 4-5 individual colonies of same morphology was picked up and 
inoculated into peptone water and incubated at 35ºC for 2 hours. The turbidity of the 
inoculum was then adjusted with sterile saline to get s turbidity optically comparable 
to  the  0.5  McFarland  standard.  Using  a  micropipette  2µl  of  the  inoculum  was 
delivered on the agar surface which gave an approximate strength of 10 4 cfu/ml. The 
plates were then incubated at 35ºC overnight.
RESULT: The lowest concentration of the antibiotic which inhibited the growth 
of the organisms was taken as the MIC.
MIC 50: The concentration of the antibiotic at which 50% of the test strains was 
inhibited was taken as the MIC50. 
MIC  90: The concentration of the antibiotic at which 90% of the test strains are 
Inhibited was taken as the MIC90. 
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